Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

CURRICULUM VITAE

Kathleen K. Christians MD
Professor
Department of Surgery
Division of Surgical Oncology

OFFICE ADDRESS:
MCW Business Group
8701 Watertown Plank Rd
Milwaukee, WI 53226

COMMUNITY SERVICE ACTIVITIES:
Volunteer Physician - Wisconsin's 1st Annual Camp for Burn Injured Youth.
 


BIBLIOGRAPHY
Refereed Journal Publications/Original Papers
1. Tsai S, Christians KK, George B, Ritch PS, Dua K, Khan A, Mackinnon AC, Tolat P, Ahmad SA, Hall WA, Erickson BA, Evans DB. A Phase II Clinical Trial of Molecular Profiled Neoadjuvant Therapy for Localized Pancreatic Ductal Adenocarcinoma. Ann Surg. 2018 10;268(4):610-619.
2. Liu C, Berger NG, Rein L, Tarima S, Clarke C, Mogal H, Christians KK, Tsai S, Gamblin TC. Gallbladder carcinoma: An analysis of the national cancer data base to examine hispanic influence. J Surg Oncol. 2018 Jun;117(8):1664-1671.
3. Berger NG, Herren JL, Liu C, Burrow RH, Silva JP, Tsai S, Christians KK, Gamblin TC. Ablation approach for primary liver tumors: Peri-operative outcomes. J Surg Oncol. 2018 Jun;117(7):1493-1499.
4. Silva JP, Berger NG, Yin Z, Liu Y, Tsai S, Christians KK, Clarke CN, Mogal H, Gamblin TC. The effect of prior upper abdominal surgery on outcomes after liver transplantation for hepatocellular carcinoma: An analysis of the database of the organ procurement transplant network. Surgery. 2018 05;163(5):1028-1034.
5. Chatzizacharias NA, Tsai S, Griffin M, Tolat P, Ritch P, George B, Barnes C, Aldakkak M, Khan AH, Hall W, Erickson B, Evans DB, Christians KK. Locally advanced pancreas cancer: Staging and goals of therapy. Surgery. 2018 05;163(5):1053-1062.
6. Silva JP, Berger NG, Yin Z, Liu Y, Tsai S, Christians KK, Clarke CN, Mogal H, Clark Gamblin T. Minimally invasive hepatectomy conversions: an analysis of risk factors and outcomes. HPB (Oxford). 2018 02;20(2):132-139.
7. Bhalla M, Aldakkak M, Kulkarni NM, O'Connor SD, Griffin MO Jr, Christians KK, Evans DB, Tsai S, Tolat PP. Characterizing indeterminate liver lesions in patients with localized pancreatic cancer at the time of diagnosis. Abdom Radiol (NY). 2018 02;43(2):351-363.
8. Barnes CA, Krzywda E, Lahiff S, McDowell D, Christians KK, Knechtges P, Tolat P, Hohenwalter M, Dua K, Khan AH, Evans DB, Geurts J, Tsai S. Development of a high risk pancreatic screening clinic using 3.0A T MRI. Fam Cancer. 2018 01;17(1):101-111.
9. Berger NG, Silva JP, Mogal H, Clarke CN, Bedi M, Charlson J, Christians KK, Tsai S, Gamblin TC. Overall survival after resection of retroperitoneal sarcoma at academic cancer centers versus community cancer centers: An analysis of the National Cancer Data Base. Surgery. 2018 02;163(2):318-323.
10. Blitzer GC, Hall WA, Tsai S, Aldakkak M, Hellman RS, Evans DB, Christians KK, George B, Ritch PS, Erickson BA. Should functional renal scans be obtained prior to upper abdominal IMRT for pancreatic cancer? Pract Radiat Oncol. 2017 Nov - Dec;7(6):e449-e455.
11. Barnes CA, Krepline AN, Aldakkak M, Clarke CN, Christians KK, Khan AH, Hunt BC, Ritch PS, George B, Hall WA, Erickson BA, Evans DB, Tsai S. Is Adjuvant Therapy Necessary for All Patients with Localized Pancreatic Cancer Who Have Received Neoadjuvant Therapy? J Gastrointest Surg. 2017 Nov;21(11):1793-1803.
12. Silva JP, Gorman RA, Berger NG, Tsai S, Christians KK, Clarke CN, Mogal H, Gamblin TC. The prognostic utility of baseline alpha-fetoprotein for hepatocellular carcinoma patients. J Surg Oncol. 2017 Dec;116(7):831-840.
13. Silva JP, Berger NG, Tsai S, Christians KK, Clarke CN, Mogal H, White S, Rilling W, Gamblin TC. Transarterial chemoembolization in hepatocellular carcinoma with portal vein tumor thrombosis: a systematic review and meta-analysis. HPB (Oxford). 2017 08;19(8):659-666.
14. Berger NG, Tanious MN, Hammad AY, Miura JT, Mogal H, Clarke CN, Christians KK, Tsai S, Gamblin TC. External radiation or ablation for solitary hepatocellular carcinoma: A survival analysis of the SEER database. J Surg Oncol. 2017 Sep;116(3):307-312.
15. Younan G, Tsai S, Evans DB, Christians KK. A Novel Reconstruction Technique During Pancreaticoduodenectomy After Roux-En-Y Gastric Bypass: How I do It. J Gastrointest Surg. 2017 07;21(7):1186-1191. PMCID: PMC5486682
16. Abdelkader A, Lam CA, Shahir KS, Christians K, Suster SM. Retroperitoneal lymphangioleiomyoma with lymph node involvement: A pathologic-radiologic correlation of a rare form of myomelanocytic tumor. Ann Diagn Pathol. 2017 Apr;27:69-73.
17. Hammad AY, Robbins JR, Turaga KK, Christians KK, Gamblin TC, Johnston FM. Palliative interventions for hepatocellular carcinoma patients: analysis of the National Cancer Database. Ann Palliat Med. 2017 Jan;6(1):26-35.
18. Rajamanickam ES, Christians KK, Aldakkak M, Krepline AN, Ritch PS, George B, Erickson BA, Foley WD, Aburajab M, Evans DB, Tsai S. Poor Glycemic Control Is Associated with Failure to Complete Neoadjuvant Therapy and Surgery in Patients with Localized Pancreatic Cancer. J Gastrointest Surg. 2017 03;21(3):496-505.
19. Younan G, Tsai S, Evans DB, Christians KK. Techniques of Vascular Resection and Reconstruction in Pancreatic Cancer. Surg Clin North Am. 2016 Dec;96(6):1351-1370.
20. Tsai S, Christians KK, Ritch PS, George B, Khan AH, Erickson B, Evans DB. Multimodality Therapy in Patients With Borderline Resectable or Locally Advanced Pancreatic Cancer: Importance of Locoregional Therapies for a Systemic Disease. J Oncol Pract. 2016 10;12(10):915-923.
21. Krepline AN, Christians KK, George B, Ritch PS, Erickson BA, Tolat P, Evans DB, Tsai S. Venous thromboembolism prophylaxis during neoadjuvant therapy for resectable and borderline resectable pancreatic cancer-Is it indicated? J Surg Oncol. 2016 Oct;114(5):581-586.
22. Younan G, Schumm M, Ali F, Christians KK. Gallbladder Volvulus in a Patient with Type I Choledochal Cyst: A Case Report and Review of the Literature. Case Rep Surg. 2016;2016:5626531. PMCID: PMC5055938
23. Younan G, Chimukangara M, Tsai S, Evans DB, Christians KK. Replaced gastroduodenal artery: Added benefit of the "artery first" approach during pancreaticoduodenectomy-A case report. Int J Surg Case Rep. 2016;23:93-7. PMCID: PMC4855750
24. Christians KK, Heimler JW, George B, Ritch PS, Erickson BA, Johnston F, Tolat PP, Foley WD, Evans DB, Tsai S. Survival of patients with resectable pancreatic cancer who received neoadjuvant therapy. Surgery. 2016 Mar;159(3):893-900.
25. Potkonjak M, Miura JT, Turaga KK, Johnston FM, Tsai S, Christians KK, Gamblin TC. Intrahepatic cholangiocarcinoma and gallbladder cancer: distinguishing molecular profiles to guide potential therapy. HPB (Oxford). 2015 Dec;17(12):1119-23. PMCID: PMC4644364
26. Larrieux G, Wachi BI, Miura JT, Turaga KK, Christians KK, Gamblin TC, Peltier WL, Weissman DE, Nattinger AB, Johnston FM. Palliative Care Training in Surgical Oncology and Hepatobiliary Fellowships: A National Survey of Program Directors. Ann Surg Oncol. 2015 Dec;22 Suppl 3:S1181-6.
27. Fathi A, Christians KK, George B, Ritch PS, Erickson BA, Tolat P, Johnston FM, Evans DB, Tsai S. Neoadjuvant therapy for localized pancreatic cancer: guiding principles. J Gastrointest Oncol. 2015 Aug;6(4):418-29. PMCID: PMC4502155
28. Aldakkak M, Christians KK, Krepline AN, George B, Ritch PS, Erickson BA, Johnston FM, Evans DB, Tsai S. Pre-treatment carbohydrate antigen 19-9 does not predict the response to neoadjuvant therapy in patients with localized pancreatic cancer. HPB (Oxford). 2015 Oct;17(10):942-52. PMCID: PMC4571763
29. Miura JT, Krepline AN, George B, Ritch PS, Erickson BA, Johnston FM, Oshima K, Christians KK, Evans DB, Tsai S. Use of neoadjuvant therapy in patients 75 years of age and older with pancreatic cancer. Surgery. 2015 Dec;158(6):1545-55.
30. Miura JT, Johnston FM, Tsai S, Eastwood D, Banerjee A, Christians KK, Turaga KK, Gamblin TC. Surgical resection versus ablation for hepatocellular carcinoma a?? 3 cm: a population-based analysis. HPB (Oxford). 2015 Oct;17(10):896-901. PMCID: PMC4571757
31. Miura JT, Johnston FM, Tsai S, George B, Thomas J, Eastwood D, Banerjee A, Christians KK, Turaga KK, Pawlik TM, Clark Gamblin T. Chemotherapy for Surgically Resected Intrahepatic Cholangiocarcinoma. Ann Surg Oncol. 2015 Oct;22(11):3716-23.
32. Groeschl RT, Riggle KM, Quebbeman EJ, Christians KK, Turaga KK, Tsai S, Gamblin TC. Hepatectomy for hemangioma; safe, but is it successful? Hepatogastroenterology. 2014 Oct;61(135):2009-13.
33. Christians KK, Evans DB. Additional support for neoadjuvant therapy in the management of pancreatic cancer. Ann Surg Oncol. 2015 Jun;22(6):1755-8.
34. Kharofa J, Tsai S, Kelly T, Wood C, George B, Ritch P, Wiebe L, Christians K, Evans DB, Erickson B. Neoadjuvant chemoradiation with IMRT in resectable and borderline resectable pancreatic cancer. Radiother Oncol. 2014 Oct;113(1):41-6. PMCID: PMC4530020
35. Amini A, Miura JT, Jayakrishnan TT, Johnston FM, Tsai S, Christians KK, Gamblin TC, Turaga KK. Is local resection adequate for T1 stage ampullary cancer? HPB (Oxford). 2015 Jan;17(1):66-71. PMCID: PMC4266442
36. Amini A, Miura JT, Larrieux G, Tsai S, Turaga KK, Christians KK, Brasel KJ, Clark Gamblin T, Weissman DE, Nattinger AB, Johnston FM. Palliative care training in surgical oncology and hepatobiliary fellowships: a national survey of the fellows. Ann Surg Oncol. 2015;22(6):1761-7.
37. Krepline AN, Christians KK, Duelge K, Mahmoud A, Ritch P, George B, Erickson BA, Foley WD, Quebbeman EJ, Turaga KK, Johnston FM, Gamblin TC, Evans DB, Tsai S. Patency rates of portal vein/superior mesenteric vein reconstruction after pancreatectomy for pancreatic cancer. J Gastrointest Surg. 2014 Nov;18(11):2016-25.
38. Miura JT, Jayakrishnan TT, Amini A, Johnston FM, Tsai S, Erickson B, Quebbeman EJ, Christians KK, Evans DB, Gamblin TC, Turaga KK. Defining the role of adjuvant external beam radiotherapy on resected adenocarcinoma of the ampulla of vater. J Gastrointest Surg. 2014 Nov;18(11):2003-8.
39. Jayakrishnan TT, Nadeem H, Groeschl RT, George B, Thomas JP, Ritch PS, Christians KK, Tsai S, Evans DB, Pappas SG, Gamblin TC, Turaga KK. Diagnostic laparoscopy should be performed before definitive resection for pancreatic cancer: a financial argument. HPB (Oxford). 2015 Feb;17(2):131-9. PMCID: PMC4299387
40. Miura JT, Amini A, Schmocker R, Nichols S, Sukato D, Winslow ER, Spolverato G, Ejaz A, Squires MH, Kooby DA, Maithel SK, Li A, Wu MC, Sarmiento JM, Bloomston M, Christians KK, Johnston FM, Tsai S, Turaga KK, Tsung A, Pawlik TM, Gamblin TC. Surgical management of hepatic hemangiomas: a multi-institutional experience. HPB (Oxford). 2014 Oct;16(10):924-8. PMCID: PMC4238859
41. Miura JT, Johnston FM, Thomas J, George B, Eastwood D, Tsai S, Christians KK, Turaga KK, Gamblin TC. Molecular profiling in gastric cancer: examining potential targets for chemotherapy. J Surg Oncol. 2014 Sep;110(3):302-6.
42. Christians KK, Pilgrim CH, Tsai S, Ritch P, George B, Erickson B, Tolat P, Evans DB. Arterial resection at the time of pancreatectomy for cancer. Surgery. 2014 May;155(5):919-26.
43. Christians KK, Tsai S, Mahmoud A, Ritch P, Thomas JP, Wiebe L, Kelly T, Erickson B, Wang H, Evans DB, George B. Neoadjuvant FOLFIRINOX for borderline resectable pancreas cancer: a new treatment paradigm? Oncologist. 2014 Mar;19(3):266-74. PMCID: PMC3958454
44. Pilgrim CH, Evans DB, Christians KK. Reply: To PMID 23816382. J Am Coll Surg. 2014 Feb;218(2):307-8.
45. Pilgrim CH, Tsai S, Tolat P, Patel P, Rilling W, Evans DB, Christians KK. Optimal management of the splenic vein at the time of venous resection for pancreatic cancer: importance of the inferior mesenteric vein. J Gastrointest Surg. 2014 May;18(5):917-21.
46. Sullivan KM, Groeschl RT, Turaga KK, Tsai S, Christians KK, White SB, Rilling WS, Pilgrim CH, Gamblin TC. Neutrophil-to-lymphocyte ratio as a predictor of outcomes for patients with hepatocellular carcinoma: a Western perspective. J Surg Oncol. 2014 Feb;109(2):95-7.
47. Groeschl RT, Pilgrim CH, Hanna EM, Simo KA, Swan RZ, Sindram D, Martinie JB, Iannitti DA, Bloomston M, Schmidt C, Khabiri H, Shirley LA, Martin RC, Tsai S, Turaga KK, Christians KK, Rilling WS, Gamblin TC. Microwave ablation for hepatic malignancies: a multiinstitutional analysis. Ann Surg. 2014 Jun;259(6):1195-200.
48. Pappas SG, Pilgrim CH, Keim R, Harris R, Wilson S, Turaga K, Tsai S, Dua K, Khan A, Oh Y, Gamblin TC, Christians K. The Frey procedure for chronic pancreatitis secondary to pancreas divisum. JAMA Surg. 2013 Nov;148(11):1057-62.
49. Christians KK, Pappas S, Pilgrim C, Tsai S, Quebbeman E. Duplicate pancreas meets gastric duplication cyst: A tale of two anomalies. Int J Surg Case Rep. 2013;4(8):735-9. PMCID: PMC3710888
50. Pilgrim CH, Tsai S, Evans DB, Christians KK. Mesocaval shunting: a novel technique to facilitate venous resection and reconstruction and enhance exposure of the superior mesenteric and celiac arteries during pancreaticoduodenectomy. J Am Coll Surg. 2013 Sep;217(3):e17-20.
51. Groeschl RT, Hong JC, Christians KK, Turaga KK, Tsai S, Pilgrim CH, Gamblin TC. Viral status at the time of liver transplantation for hepatocellular carcinoma: a modern predictor of longterm survival. HPB (Oxford). 2013 Oct;15(10):794-802. PMCID: PMC3791119
52. Pappas SG, Christians KK, Tolat PP, Mautz AP, Lal A, McElroy L, Gamblin TC, Turaga KK, Tsai S, Erickson B, Ritch P, Evans DB. Staging chest computed tomography and positron emission tomography in patients with pancreatic adenocarcinoma: utility or futility? HPB (Oxford). 2014 Jan;16(1):70-4. PMCID: PMC3892317
53. Pilgrim CH, Groeschl RT, Christians KK, Gamblin TC. Modern perspectives on factors predisposing to the development of gallbladder cancer. HPB (Oxford). 2013 Nov;15(11):839-44. PMCID: PMC4503280
54. Groeschl RT, Wong RK, Quebbeman EJ, Tsai S, Turaga KK, Pappas SG, Christians KK, Hohenwalter EJ, Tutton SM, Rilling WS, Gamblin TC. Recurrence after microwave ablation of liver malignancies: a single institution experience. HPB (Oxford). 2013 May;15(5):365-71. PMCID: PMC3633038
55. Christians KK, Riggle K, Keim R, Pappas S, Tsai S, Ritch P, Erickson B, Evans DB. Distal splenorenal and temporary mesocaval shunting at the time of pancreatectomy for cancer: initial experience from the Medical College of Wisconsin. Surgery. 2013 Jul;154(1):123-31.
56. Groeschl RT, Christians KK, Turaga KK, Gamblin TC. Management of primary hepatopancreatobiliary small cell carcinoma. J Surg Oncol. 2013 Jun;107(7):692-5.
57. Christians KK, Tsai S, Tolat PP, Evans DB. Critical steps for pancreaticoduodenectomy in the setting of pancreatic adenocarcinoma. J Surg Oncol. 2013 Jan;107(1):33-8.
58. Kiefer MV, Albert M, McNally M, Robertson M, Sun W, Fraker D, Olthoff K, Christians K, Pappas S, Rilling W, Soulen MC. Chemoembolization of intrahepatic cholangiocarcinoma with cisplatinum, doxorubicin, mitomycin C, ethiodol, and polyvinyl alcohol: a 2-center study. Cancer. 2011 Apr 01;117(7):1498-505.
59. Gamblin TC, Christians K, Pappas SG. Radiofrequency ablation of neuroendocrine hepatic metastasis. Surg Oncol Clin N Am. 2011 Apr;20(2):273-9, vii-viii.
60. Lal A, Christians K, Evans DB. Management of borderline resectable pancreatic cancer. Surg Oncol Clin N Am. 2010 Apr;19(2):359-70.
61. Pitt SC, Pitt HA, Baker MS, Christians K, Touzios JG, Kiely JM, Weber SM, Wilson SD, Howard TJ, Talamonti MS, Rikkers LF. Small pancreatic and periampullary neuroendocrine tumors: resect or enucleate? J Gastrointest Surg. 2009 Sep;13(9):1692-8. PMCID: PMC3354713
62. Christians K, Evans DB. Pancreaticoduodenectomy and vascular resection: persistent controversy and current recommendations. Ann Surg Oncol. 2009 Apr;16(4):789-91.
63. Christians K, Brasel K, Garlitz J, Abu-Hajir M, Gottschall J. The use of recombinant activated factor VII in trauma-associated hemorrhage with crush injury. J Trauma. 2005 Sep;59(3):742-6.
64. Tsai S, George B, Wittmann D, Ritch PS, Krepline AN, Aldakkak M, Barnes CA, Christians KK, Dua K, Griffin M, Hagen C, Hall WA, Erickson BA, Evans DB. Importance of Normalization of CA19-9 Levels Following Neoadjuvant Therapy in Patients With Localized Pancreatic Cancer. Ann Surg. 2020 04;271(4):740-747.
65. Wilkinson KH, Ethun CG, Hembrook M, Bedi M, Charlson J, Mogal H, Tsai S, Christians K, Tran TB, Poultsides G, Grignol V, Howard JH, Tseng J, Roggin KK, Chouliaras K, Votanopoulos K, Cullinan D, Fields RC, Weber S, Gamblin TC, Cardona K, Clarke CN. Outcomes of Elderly Patients Undergoing Curative Resection for Retroperitoneal Sarcomas: Analysis From the US Sarcoma Collaborative. J Surg Res. 2019 01;233:154-162.
66. Chavez MI, Tsai S, Clarke CN, Aldakkak M, Griffin MO, Khan AH, Ritch PS, Erickson BA, Evans DB, Christians KK. Distal splenorenal and mesocaval shunting at the time of pancreatectomy. Surgery. 2019 02;165(2):298-306.
67. Silva JP, Klooster B, Tsai S, Christians KK, Clarke CN, Mogal H, Clark Gamblin T. Elective Regional Therapy Treatment for Hepatic Adenoma. Ann Surg Oncol. 2019 Jan;26(1):125-130.
68. Silva JP, Maurina MN, Tsai S, Christians KK, Clarke CN, Mogal H, Saeian K, Gamblin TC. Effect of Donor Race-Matching on Overall Survival for African-American Patients Undergoing Liver Transplantation for Hepatocellular Carcinoma. J Am Coll Surg. 2019 03;228(3):245-254.
69. Morgan Z, Chow BE, Strong EA, Tsai S, Christians K, Mogal H, Gamblin TC, Clarke CN. RAS Mutation Status Confers Prognostic Relevance in Patients Treated With Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Colorectal Cancer. J Surg Res. 2019 08;240:130-135.
70. Barnes CA, Chavez MI, Tsai S, Aldakkak M, George B, Ritch PS, Dua K, Clarke CN, Tolat P, Hagen C, Hall WA, Erickson BA, Evans DB, Christians KK. Survival of patients with borderline resectable pancreatic cancer who received neoadjuvant therapy and surgery. Surgery. 2019 09;166(3):277-285.
71. Evans DB, Tolat PP, Christians KK. Pancreaticoduodenectomy and total pancreatectomy for cancer Fischer's Mastery of Surgery, Seventh Edition. 1 January 2018;2:1552-1572.
72. Fathi AH, Tsai S, Lee JE, Evans DB, Christians KK. Venous shunting procedures for borderline resectable pancreatic cancer Multimodality Management of Borderline Resectable Pancreatic Cancer. 10 December 2015:237-245.
73. Younan G, Evans DB, Christians KK. Cavernous transformation of the portal vein requiring temporary mesocaval shunt and internal jugular vein interposition graft Case-Based Lessons in the Management of Complex Hepato-Pancreato-Biliary Surgery. 18 March 2017:375-383.
74. Tsai S, George B, Christians KK, Evans DB. Neoadjuvant Chemotherapy and Radiochemotherapy: Is There a Survival Advantage for Pancreatic Cancer Patients? Pancreatic Cancer, Cystic Neoplasms and Endocrine Tumors: Diagnosis and Management. 7 April 2015:103-119.
75. Pilgrim CHC, Evans DB, Christians KK. Technical aspects of pancreatic surgery Handbook of Pancreatic and Hepatobiliary Surgery. 9 September 2014.
76. Evans DB, Christians KK, Foley WD. Pancreaticoduodenectomy (whipple operation) and total pancreatectomy for cancer Fischer's Mastery of Surgery: Sixth Edition. 20 February 2012;1.
77. Christians K, Evans DB. Erratum: Pancreaticoduodenectomy and vascular resection: Persistent controversy and current recommendations (Annals of Surgical Oncology (2009) 16 (789-791) DOI: 10.1245/s10434-009-0322-y) Annals of Surgical Oncology. August 2009;16(8):2380.
78. Christians KK, Weigelt JA. Ultrasound use in the intensive care unit Operative Techniques in General Surgery. September 2003;5(3):158-165.
79. Jariwalla NR, Khan AH, Dua K, Christians KK, Clarke CN, Aldakkak M, George B, Tutton S, Rilling W, Erickson B, Evans DB, Tsai S. Management of Acute Cholecystitis during Neoadjuvant Therapy in Patients with Pancreatic Adenocarcinoma. Ann Surg Oncol. 2019 Dec;26(13):4515-4521.
80. Krepline AN, Bliss L, Geurts J, Akinola I, Christians KK, George B, Ritch PS, Hall WA, Erickson BA, Evans DB, Tsai S. Role of Molecular Profiling of Pancreatic Cancer After Neoadjuvant Therapy: Does it Change Practice? J Gastrointest Surg. 2020 02;24(2):235-242.
81. Coon C, Berger N, Eastwood D, Tsai S, Christians K, Mogal H, Clarke C, Gamblin TC. Primary Liver Cancer: An NCDB Analysis of Overall Survival and Margins After Hepatectomy. Ann Surg Oncol. 2020 Apr;27(4):1156-1163.
82. Rowan DJ, Hartley CP, Aldakkak M, Christians KK, Evans DB, Tsai S, Hagen CE. Gross tumor size using the AJCC 8th ed. T staging criteria does not provide prognostic stratification for neoadjuvant treated pancreatic ductal adenocarcinoma Annals of Diagnostic Pathology. June 2020;46.
83. Barnes CA, Aldakkak M, Clarke CN, Christians KK, Bucklan D, Holt M, Tolat P, Ritch PS, George B, Hall WA, Erickson BA, Evans DB, Tsai S. Value of Pretreatment <sup>18</sup>F-fluorodeoxyglucose Positron Emission Tomography in Patients With Localized Pancreatic Cancer Treated With Neoadjuvant Therapy. Front Oncol. 2020;10:500. PMCID: PMC7180175
84. Wittmann D, Hall WA, Christians KK, Barnes CA, Jariwalla NR, Aldakkak M, Clarke CN, George B, Ritch PS, Riese M, Khan AH, Kulkarni N, Evans J, Erickson BA, Evans DB, Tsai S. Impact of Neoadjuvant Chemoradiation on Pathologic Response in Patients With Localized Pancreatic Cancer. Front Oncol. 2020;10:460. PMCID: PMC7175033
85. Muraki T, Reid MD, Pehlivanoglu B, Gonzalez RS, Sekhar A, Memis B, Xue Y, Cheng J, Jang KT, Mittal P, Cardona K, Kooby DA, Maithel S, Sarmiento JM, El-Rayes B, Lomberk G, Urrutia RA, Christians K, Tsai S, Evans DB, Adsay V. Variant anatomy of the biliary system as a cause of pancreatic and peri-ampullary cancers. HPB (Oxford). 2020 12;22(12):1675-1685.
86. Thalji SZ, Tsai S, Gamblin TC, Clarke C, Christians K, Charlson J, Ethun CG, Poultsides G, Grignol VP, Roggin KK, Votanopoulos K, Fields RC, Abbott DE, Cardona K, Mogal H, other members of the US Sarcoma Collaborative. Outcomes of palliative-intent surgery in retroperitoneal sarcoma-Results from the US Sarcoma Collaborative. J Surg Oncol. 2020 Jun;121(7):1140-1147.
87. Krepline AN, Geurts JL, Akinola I, Christians KK, Clarke CN, George B, Ritch PS, Khan AH, Hall WA, Erickson BA, Griffin MO, Evans DB, Tsai S. Detection of germline variants using expanded multigene panels in patients with localized pancreatic cancer HPB. 2020.
88. Liu C, Rein L, Clarke C, Mogal H, Tsai S, Christians KK, Gamblin TC. Comparison of overall survival in gallbladder carcinoma at academic versus community cancer centers: An analysis of the National Cancer Data Base. J Surg Oncol. 2020 Aug;122(2):176-182.
89. Krepline AN, Geurts JL, Akinola I, Christians KK, Clarke CN, George B, Ritch PS, Khan AH, Hall WA, Erickson BA, Griffin MO, Evans DB, Tsai S. Detection of germline variants using expanded multigene panels in patients with localized pancreatic cancer. HPB (Oxford). 2020 12;22(12):1745-1752.
90. Rowan DJ, Hartley CP, Aldakkak M, Christians KK, Evans DB, Tsai S, Hagen CE. Gross tumor size using the AJCC 8th ed. T staging criteria does not provide prognostic stratification for neoadjuvant treated pancreatic ductal adenocarcinoma. Ann Diagn Pathol. 2020 Jun;46:151485.
91. Barnes CA, Aldakkak M, Christians KK, Clarke CN, Dua K, George B, Ritch PS, Kamgar M, Hall WA, Kulkarni N, Erickson BA, Evans DB, Tsai S. Radiographic patterns of first disease recurrence after neoadjuvant therapy and surgery for patients with resectable and borderline resectable pancreatic cancer Surgery (United States). 2020.
92. Strong EA, Park SH, Ethun CG, Chow B, King D, Bedi M, Charlson J, Mogal H, Tsai S, Christians K, Tran TB, Poultsides G, Grignol V, Howard JH, Tseng J, Roggin KK, Chouliaras K, Votanopoulos K, Cullinan D, Fields RC, Gamblin TC, Cardona K, Clarke CN. High neutrophil-lymphocyte ratio is not independently associated with worse survival or recurrence in patients with extremity soft tissue sarcoma. Surgery. 2020 10;168(4):760-767.
93. Barnes CA, Aldakkak M, Christians KK, Clarke CN, Dua K, George B, Ritch PS, Kamgar M, Hall WA, Kulkarni N, Erickson BA, Evans DB, Tsai S. Radiographic patterns of first disease recurrence after neoadjuvant therapy and surgery for patients with resectable and borderline resectable pancreatic cancer. Surgery. 2020 09;168(3):440-447.
94. Hagen CE, Christians K, Hopp A, Giorgadze T, Hartley CP, Hunt B, Basturk O, Klimstra D. Intraductal papillary squamous neoplasm of the pancreas: Cyto-histologic correlation of a novel entity. Ann Diagn Pathol. 2020 Oct;48:151583. PMCID: PMC8388256
95. Kim RY, Evans DB, Christians KK. Locally advanced pancreatic cancer: staging, operability, and the importance of multimodality therapy. Hepatobiliary Surg Nutr. 2020 Aug;9(4):497-500. PMCID: PMC7423551
96. Kim RY, Christians KK, Aldakkak M, Clarke CN, George B, Kamgar M, Khan AH, Kulkarni N, Hall WA, Erickson BA, Evans DB, Tsai S. Total Neoadjuvant Therapy for Operable Pancreatic Cancer. Ann Surg Oncol. 2021 Apr;28(4):2246-2256.
97. Christians KK. Commentary: Venous resection and reconstruction at the time of pancreatectomy for cancer. Surgery. 2020 12;168(6):1058-1059.
98. Chavez MI, Gholami S, Kim BJ, Margonis GA, Ethun CG, Tsai S, Christians KK, Clarke C, Mogal H, Maithel SK, Pawlik TM, Da??Angelica MI, Aloia TA, Eastwood D, Gamblin TC. Two-Stage Hepatectomy for Bilateral Colorectal Liver Metastases: A Multi-institutional Analysis Annals of Surgical Oncology. 2021.
99. Mora J, Krepline AN, Aldakkak M, Christians KK, George B, Hall WA, Erickson BA, Kulkarni N, Evans DB, Tsai S. Adjuvant therapy rates and overall survival in patients with localized pancreatic cancer from high Area Deprivation Index neighborhoods. Am J Surg. 2021 07;222(1):10-17.
100. Chavez MI, Gholami S, Kim BJ, Margonis GA, Ethun CG, Tsai S, Christians KK, Clarke C, Mogal H, Maithel SK, Pawlik TM, D'Angelica MI, Aloia TA, Eastwood D, Gamblin TC. Two-Stage Hepatectomy for Bilateral Colorectal Liver Metastases: A Multi-institutional Analysis. Ann Surg Oncol. 2021 Mar;28(3):1457-1465. PMCID: PMC8385606
101. Calkins, C., Christians, K., Sell, L.: Cost Analysis in the Management of Esophageal Coins: Endoscopy vs. Bougienage. J Pediatr Surg. 1999; 34(3): 412-414. PMID 10211643.
102. Wallace, J., Christians, K., Pitt, H., Quebbeman, E.: Cryotherapy Extends the Indications for Treatment of Colorectal Liver Metastases. Presented at Central Surgical Association, St Louis, MO 3/4/99. Surgery. 1999; 126(4): 766-774. PMID 10520927.
103. Wallace, J., Christians, K., Quiroz, F., Foley, W., Pitt, H., Quebbeman, E.: Ablation of Liver Metastasis: Is Preoperative Imaging Sufficiently Accurate? Presented at SSAT San Diego, CA 5/21/2000. J of Gastrointest Surg. 2001; 5(1): 98-107. PMID: 11309654.
104. Christians, K., Pitt, H., Rilling, W., Franco, J., Quiroz, F., Adams, M., Wallace, J., Quebbeman, E.: Hepatocellular Carcinoma: Multimodality Management. Surgery. 2001; 130(4): 554-560. PMID: 11602884.
105. Christians, K., Wu, C., Quebbeman, E., Brasel, K.: Postoperative Atrial Fibrillation in Non-cardiothoracic Surgical Patients - Clinical Correlations and Outcome. Presented at Southwest Surgical Cancun, Mexico 5/2/01. Am J Surg. 2001; 182(6): 713-715. PMID: 11839344.
106. Brasel, K.J., Weigelt, J.A., Christians, K., Somberg, L.B.: The Value of Process Measures in Evaluating an Evidence-Based Guideline. Surgery. 2003; 134(4): 605-612. PMID: 14605621.
107. Christians, K., Brasel, K.J., Garlitz, J., et al.: Use of Recombinant Activated Factor VII in Trauma Associated Hemorrhage with Crush Injury. J Trauma. 2005; 59(3): 742-746. PMID 16361923.
108. Kiely, J.M., Brasel, K.J., Graewin, S.J., Nowak, D., Christians, K., Nirula, R.: Crohn's Disease Presenting as Necrotizing Fascitis: A Case Report. Am Surg. 2005; 71(10): 870-871. PMID: 16468538.
109. Pitt, S., Pitt, H., Baker, M., Christians, K., et al.: Small Pancreatic and Periampullary Neuroendocrine Tumors: Resect or Enucleate? J Gastrointest Surg, 2009; 13:1692-1698. PMID: 19548038.
110. Parker S, Olteanu H, Lawton C, Schultz C, Christians K, Fenske T. Follicular Lymphoma Transformation to Dual Translocated Burkitt-Like Lymphoma: Improved Disease Control Associated with Radiation Therapy. Int J of Hematol. 2009; 90(5):616-622. PMID: 19937165
111. Christians, K. and Evans, D.: Pancreaticoduodenectomy and Vascular Resection: Persistent Controversy and Current Recommendations. Ann of Surg Oncol. 2009; 16(4): 789-91.
112. Christians, K., Lal, A., Pappas, S., Quebbeman, E., Evans, D.: Portal Vein Resection. Surg Clin North Am. 2010; 90(2):309-22.
113. Lal, A., Christians, K., Evans, D.: Management of Borderline Resectable Pancreatic Cancer. Surgical Oncol Clin N Am. 2010; 19(2): 359-370. PMID: 20159519.
114. Gamblin TC, Christians K, Pappas SG. Radiofrequency Ablation of Neuroendocrine Hepatic Metastases, Surg Oncol Clin N Am. 2010; 90(4):737-48.
115. Kiefer, MV, Albert, M., McNally, M., Robertson, M., Weijing, S., Fraker, D., Olthoff, K., Christians, K., Pappas, S., Rilling, W., Soulen, M.: Chemoembolization of Intrahepatic Cholangiocarcinoma with Cisplatinum, Adriamycin, Mitomycin C, Ethiodol, and Polyvinyl Alcohol. Cancer. 2011; 117(7): 1498-505. PMID: 21425151.
116. Wilson SD, Doffek KM, Krzywda EA, Quebbeman EJ, Christians KK, Pappas SG: Zollinger-Ellison Syndrome Associated with a History of Alcohol Abuse: Coincidence or Consequence? Presented at American Association of Endocrine Surgeons Houston, Tx 4/11/11. Surgery. 2011; 150(6):1129-35. PMID: 221136832.
117. Pappas SG, Christians KK, Harris R, Wilson S, Turaga K, Tsai S, Dua K, Khan A, Oh Y, Gamblin TC, Keim R. The Frey procedure for chronic pancreatitis secondary to pancreas divisum. JAMA Surg. 2013; Nov:148(11):1057-62. PMID: 24005579
118. Christians KK, Tsai S, Tolat P, Evans DB. Critical Steps for Pancreaticoduodenectomy in the Setting of Pancreatic Adenocarcinoma. J Surg Oncol. 2013; 107(1):33-8. PMID 22711619.
119. Christians KK, Riggle K, Keim R, Pappas S, Tsai S, Ritch P, Erickson B and Evans DB. Distal Splenorenal and Temporary Mesocaval Shunting at the Time of Pancreatectomy for Cancer: Initial Experience from the Medical College of Wisconsin. Presented at AHPBA, Miami, FL 3/11/12. Surgery 2013; 154(1):123-31. PMID: 23305596.
120. Groeschl RT, Wong RK, Quebbeman EJ, Tsai S, Turaga KT, Pappas SG, Christians KK, Hohenwalter EJ, Tutton SM, Rilling WS and Gamblin TC. Recurrence after Microwave Ablation of Liver Malignancies - A Single Institution Experience. Presented at 10th World Congress - IHPBA (Paris, France): July 1-5, 2012; HPB 2013; 15(5):365-71. PMID: 23458599.
121. Groeschl RT, Christians KK, Turaga KK and Gamblin TC. Management of primary hepatopancreatobiliary small cell carcinoma. Presented at Academic Surgical Congress, 2/5/13, New Orleans, LA. J Surg Oncol 2013; 107(7):692-5. PMID: 23280574.
122. Pilgrim CHC, Groeschl R, Christians KK., Gamblin TC. Modern perspectives on factors predisposing to the development of gallbladder cancer. HPB(Oxford) 2013; 15(11):839-44.
123. PMID 23458506.
124. Pappas SG, Christians KK, Tolat PP, Mautz AP, Lal A, McElroy L, Gamblin TC, Turaga KT, Tsai S, Erickson B, Ritch P and Evans DB. Staging Chest Tomography and Positron Emission Tomography in Patients with Pancreatic Adenocarcinoma: Utility or Futility?" Presented at AHPBA Miami, FL 3/2012. HPB 2014; 16(1):70-4. PMID: 23496023.
125. Christians K, Pappas S, Pilgrim C, Tsai S, Evans DB, Quebbeman. Presented at Wisconsin Surgical Society, Kohler, WI 11/7/09. Duplicate Pancreas Meets Gastric Duplication: A Tale of Two Anomalies. Int J Surg Case Rep. 2013; 4(8):735-9. PMID: 23827696.
126. Groeschl RT, Hong JC, Christians KK, Turaga KK, Tsai S, Pilgrim CHC, Gamblin TC. Viral status at the time of liver transplantation for hepatocellular carcinoma: a predictor of long-term survival in the modern era. HPB 2013; 15(10):794-802. PMID: 23782341.
127. Pappas SG, Pilgrim CHC, Keim R, Harris R, Wilson SW, Turaga K, Tsai S, Dua K, Khan A, Oh Y, Gamblin TC, Christians KK. The Frey procedure for chronic pancreatitis secondary to pancreas divisum. Presented at Association of VA Surgeons, Milwaukee WI 4/21/13. JAMA Surg. 2013; 148(11):1057-62.
128. Pilgrim C, Tsai S, Evans DB, Christians KK. Mesocaval shunting - a novel technique to facilitate venous resection and reconstruction and enhance exposure of the superior mesenteric and celiac arteries during pancreaticoduodenectomy. J Am Coll Surg 2013; 217(3):e17-20. Doi: 10.1016/j.jamcollsurg.2013.05.018. Epub 2013 June 29. PMID: 23816382.
129. Christians KK, Tsai S, Mahmoud A, Ritch P, Thomas JP, Wiebe L, Kelly T, Erickson B, Wang H, Evans DB, and George B. Neoadjuvant FOLFIRINOX for Borderline Resectable Pancreas Cancer - a New Treatment Paradigm? Oncologist. 2014; 19(3):266-74. PMID: 24569947.
130. Pilgrim CHC, Tsai S, Tolat P, Patel P, Rilling W, Evans DB, Christians KK. Optimal Management of the splenic vein at the time of venous resection for pancreatic cancer: Importance of the inferior mesenteric vein. J Gastrointest Surg. 2014 18(5):917-21. PMID: 24347313.
131. Pilgrim CH, Evans DB, Christians KK. Reply: to PMID 23816382. J Am Coll Surg. 2014 Feb;218(2):307-8. doi: 10.1016/j.jamcollsurg.2013.10.008.
132. Christians KK. Pilgrim CHC, Tsai S, Ritch P, George B, Erickson B, Tolat P, Evans DB. Arterial Resection at the Time of Pancreatectomy for Cancer. Surgery 2014; 155(5):919-26. PMID: 24787115.
133. Groeschl RT, Pilgrim CHC, Hanna EM, Simo KA, Swan RZ, Sindram D, Martinie JB, Iannitti DA, Bloomston M, Schmidt C, Khabiri H, Shirley LA, martin RCG, Tsai S, Turaga KK, Christians KK, Rilling WS, Gamblin TC. Microwave ablation for Hepatic Malignancies: A Multi-institutional Analysis. Presented at Regional Therapies 7th annual meeting Captiva, FL 2/18/12. Ann Surg. 2014; 259(6):1195-200. PMID: 2096760
134. Groeschl RT, Riggle KM, Quebbeman EJ, Christians KK, Turaga KK, Tsai S, Gamblin TC. Hepatectomy for hemangioma: safe, but is it successful? Hepatogastroenterol. 2014; 61(135):2009-13.
135. Sullivan KM, Groeschl RT, Turaga KK, Tsai S, Christians KK, White SB, Rilling WS, Pilgrim CH, Gamblin TC. Neutrophil-to-lymphocyte ratio as a predictor of outcomes for patients with hepatocellular carcinoma: a Western perspective. J Surg Oncol. 2014; 109(2):95-7. PMID: 24122764.
136. Miura JT, Amini A, Schmocker R, Nichols S, Sukato D, Winslow ER, Spolverato G, Ejaz A, Squires MH, Kooby DA, Maithel SK, Li A, Wu MG, Sarmiento JM, Bloomston M, Christians KK, Johnston FM, Tsai S, Turaga KK, Tsung A, Pawlik T, Gamblin TC. Surgical Management of Hepatic Hemangiomas: A Multi-Institutional Experience. HPB 2014 16(10):924-8. PMID: 24946109.
137. Miura, JT, Johnston FM, Thomas J, George B, Eastwood D, Tsai S, Christians KK, Turaga KK, Gamblin TC. Molecular Profiling in Gastric Cancer: Examining Potential Targets for Chemotherapy. J Surg Oncol 2014; 110(3):302-6. PMID: 24844210
138. Miura, JT, Jayakrishnan TT, Amini A, Johnston FM, Tsai S, Erickson B, Quebbeman EJ, Christian KK, Evans DB, Gamblin TC, Turaga KK. Defining the Role of Adjuvant External Beam Radiotherapy on Resected Adenocarcinoma of the Ampulla of Vater. J Gastrointest Surg. 2014; 18(11):2003-8. PMID 25159502.
139. Krepline AN, Christians KK, Duelge K, Mahmoud A, Ritch P, George B, Erickson BA, Foley WD, Quebbeman EJ, Turaga KK, Johnston FM, Gamblin TC, Evans DB, Tsai S. Patency Rates of Portal Vein/Superior Mesenteric Vein Reconstruction After Pancreatectomy for Pancreatic Adenocarcinoma. Presented at AHPBA, Miami, FL 2/21/14. J Gastrointest Surg. 2014; 18(11):2016-25. PMID: 25227638
140. Kharofa J, Tsai S, Kelly T, Wood C, George B, Ritch P, Wiebe L, Christians K, Evans DB, Erickson B. Neoadjuvant Chemoradiation with IMRT in Resectable and Borderline Resectable Pancreatic Cancer Radiotherapy and Oncology. Presented at ASTRO annual meeting, Boston, MA 10,2012. Radiother Oncol. 2014; 113(1):41-6. PMID: 25443499.
141. Jayakrishnan TT, Nadeem H, Groeschl RT, George B, Thomas JP, Ritch PS, Christians KK, Tsai S, Evans DB, Pappas SG, Gamblin TC., Turaga KK. Diagnostic Laparoscopy Should be Performed before Definitive Resection for Pancreatic Cancer: a financial Argument. Presented at AHPBA Miami, FL 2/23/14. HPB(Oxford) 2015; 17(2):131-9. PMID: 25123702.
142. Amini A, Miura JT, Larrieux G, Tsai S, Turaga KK, Christians KK, Brasel KJ, Gamblin TC, Weissman DE and Johnston FM. Palliative Care Training in Surgical Oncology and Hepatobiliary Fellowships: A National Survey of Fellows. Ann Surg Oncol 2015: 22(6):1761-7. PMID: 25380685
143. Amini, A, Miura JT, Jayakrishnan TT, Johnston FM, Tsai S, Christians KK, Gamblin TC and Turaga KK. Is Local Resection Adequate for T1 Stage Ampullary Cancer? HPB(Oxford). 2015; 17(1):66-71. PMID: 25395092.
144. Aldakkak M, Christians KK, Krepline AN, George B, Ritch PS, Erickson BA, Johnston FM, Evans DB, Tsai S. Pre-treatment Ca19-9 does not predict the response to neoadjuvant therapy in patients with localized pancreatic cancer. Presented as a long oral at AHPBA 3/13/2015. HPB(Oxford); 2015; 17(10):942-52. PMID: 26255895.
145. Miura JT, Groeschl RT, Johnston FM, Tsai S, Christians KK, Turaga KK, Gamblin TC. Surgical Resection versus Ablation for Hepatocellular Carcinoma < 3cm: A Population Based Analysis. AHPBA Annual Meeting (Singapore): March 18-21, 2015. HPB(Oxford) 2015; 17(10): 896-901. PMID 26228076.
146. Potkonjak M, Miura J, Turaga KK, Johnston F, Tsai S, Christians K, Gamblin TC. Intrahepatic Cholangiocarcinoma and Gallbladder cancer: Distinguishing Molecular Profiles to Guide Potential therapy. Presentation at Presidents Plenary Session AHPBA 3/13/15. HPB(Oxford) 2015; 17(12):1119-23. PMID 26374242.
147. Miura JT, Johnston FM, Tsai S, George B, Thomas J, Eastwood D, Banerjee A, Christians KK, Turaga KK, Gamblin TC. Chemotherapy for Surgically Resected Intrahepatic Cholangiocarcinoma. Ann Surg Oncol. 2015; 22(11):3716-23. PMID 25777092
148. Fathi A, Christians KK, George B, Ritch PS, Erickson BA, Tolat P, Johnston FM, Evans DB and Tsai S. Neoadjuvant therapy for localized pancreatic cancer: guiding principles. J Gastrointest Oncol 2015; 6(4):418-429. PMID 26261728
149. Larrieux G, Wachi BI, Miura JT, Turaga KK, Christians KK, Gamblin TC, Peltier WL, Weissman DE, Nattinger AB, Johnston FM. Palliative Care Training in Surgical Oncology and Hepatobiliary Fellowships: A National Survey of Program Directors. Ann Surg Oncol. 2015 Dec;22 Suppl 3:1181-6. PMID: 26282906.
150. Miura JT, Krepline AN, George B, Ritch PS, Erickson BA, Johnston FM, Oshima K, Christians, KK, Evans, DB, Tsai, S. Use of Neoadjuvant Therapy in patients 75 of age and older with pancreas cancer. 48th Annual Pancreas Club Meeting (Chicago, IL): May 2-4, 2014. Surgery 2015; 158(6):1545-55. PMID 26243342.
151. Christians KK, Evans DB. Additional Support for Neoadjuvant Therapy in the Management of Pancreatic Cancer. Ann Surg Oncol. 2015; 22(6):1755-8. PMID 25519932.
152. Christians KK, Heimler JW, George B, Ritch PS, Erickson BA, Johnston F, Tolat PP, Foley WD, Evans DB, and Tsai S. Survival of patients with resectable pancreatic cancer receiving neoadjuvant therapy. Presented as long oral Pancreas Club 2015. Surgery 2016; 159(3):893-900. PMID: 26602840
153. Tsai S, Christians KK, George B, Ritch P, Oshima K, Tolat P, Krepline A, Erickson BA and Evans DB. Neoadjuvant Therapy for Resectable and Borderline Resectable Pancreatic Cancer. J Cancer Therapy 2016; 7:24-40.
154. Younan G, Chimukangara M, Tsai S, Evans DB and Christians KK. Replaced Gastroduodenal Artery: Added Benefit of the "Artery First" Approach During Pancreaticoduodenectomy. Int J Surg Case Rep. 2016; 23: 93-97. PMID 27124718
155. Younan G, Schumm M, Ali F, Christians KK. Gallbladder Volvulus in a Patient with Type I Choledochal Cyst - A Case Report and Review of the Literature. Case Rep Surg. 2016; 2016:5626531. PMID: 27747125
156. Blitzer G, Aldakkak M, Christians KK, George B, Ritch P, Erickson BA, Evans DB, Tsai S. Effect of Perioperative Transfusions on Overall Survival among Patients with Localized Pancreatic Cancer Receiving Neoadjuvant Therapy. JACS 2016; 223(4):e135.
157. Blitzer G, Aldakkak M, Christians KK, George B, Ritch P, Erickson BA, Evans DB, Tsai S. Charlson Comorbidity Index and the Ability of Patients with Localized Pancreatic Cancer to Complete Neoadjuvant Therapy and Surgery. JACS 2016; 223(4): e133-e134.
158. Krepline AN, Christians KK, George B, Ritch PS, Erickson BA, Tolat P, Evans DB and Tsai S. Venous Thromboembolism Prophylaxis during Neoadjuvant Therapy for Resectable and Borderline Resectable Pancreatic Cancer - is it indicated? J Surg Oncol. 2016; 114(5):581-586. PMID: 27760280
159. Younan G, Tsai S, Evans DB, Christians KK. Techniques of Vascular Resection and Reconstruction in Pancreatic Cancer. Surg Clin North Am. 2016; 96(6): 1351-1370. PMID 27865282.
160. Tsai S, Christians KK, George B, Khan AH, Erickson BA, Evan DB. Multimodality Therapy in Patients with Borderline Resectable and Locally Advanced Pancreatic Cancer: Importance of local-regional therapies for a systemic disease. J Oncol Pract. 2016; 12(10):915-923. PMID: 27858562
161. Hammad AY, Berger NG, Eastwood D, Tsai S, Turaga KK, Christians KK, Johnston FM, Pawlik TM, Gamblin TC. Is Radiotherapy Warranted Following Intrahepatic Cholangiocarcinoma Resection? The Impact of Surgical Margins and Lymph Node Status on Survival. Ann Surg Oncol 2016; 23(Suppl 5) 912-920.
162. Blitzer GC, Hall WA, Tsai S, Aldakkak M, Hellman RS, Evans DB, Christians KK, George B, Ritch PS, Erickson BA. Should functional renal scans be obtained prior to upper abdominal IMRT for pancreatic cancer? Practical Rad Oncol 2017; 7; e449-e455.
163. Abdelkader A, Lam CA, Shahir KS, Christians K, Suster SM. Retroperitoneal lymphangioleiomyoma with lymph node involvement: A pathologic-radiologic correlation of a rare form of myomelanocytic tumor. Ann Diagn Pathol. 2017; 27:69-73. PMID: 28325364.
164. Hammad AY, Robbins JR, Turaga KT, Christians KK, Gamblin TC, Johnston FM. Palliative Interventions for Hepatocellular Carcinoma Patients: Analysis of the National Cancer Database". Ann Palliat Med. 2017; 6(1):26-35. PMID 28061532.
165. Younan G, Tsai S, Oshima K, Ballard D, Christians KK. Robotic-Assisted Distal Pancreatectomy for a Pancreatic Desmoid Tumor: A Case Report and Review of the Literature. Med Cas Rep 2017; 3(1):1-6.
166. Younan G, Tsai S, Evans DB, Christians KK. A Novel Reconstruction Technique during Pancreaticoduodenectomy after Roux-en-Y Gastric Bypass: How I Do It. J Gastrointest Surg. 2017; Jul; 21(7): 1186-1191. PMID 28447199.
167. Rajamanickam ES, Christians KK, Aldakkak M, Krepline AN, Ritch PS, George B, Erickson BA, Foley WD, Aburajab M, Evans DB and Tsai S. Poor Glycemic Control is Associated with Failure to Complete Neoadjuvant Therapy and Surgery in Patients with Localized Pancreatic Cancer. Presented at SSAT 5/23/16. J Gastrointest Surg. 2017; 21(3):496-505. PMID: 27896658.
168. Berger NG, Tanious MN, Hammad AY, Miura JT, Mogal H, Clarke CN, Christians KK, Tsai S, Gamblin TC. External radiation or ablation for solitary hepatocellular carcinoma: A survival analysis of the SEER database. J Surg Oncol. 2017 Sep; 116(3):307-312. PMID 28464313.
169. Miura JT, Berger NG, Silva JP, Tsai S, Christians KK, Gamblin TC. Defining the Influence of Gender Discordance on Survival Following Living Donor Liver Transplantation. Presented at AHPBA 3/13/15. J of Hepatol and Gastroenterol. 2017;1:002.
170. Silva JP, Gorman RA, Berger NG, Tsai S, Christians KK, Clarke CN, Mogal H, Gamblin TC. The prognostic utility of baseline alpha -fetoprotein for hepatocellular carcinoma patients.
171. J Surg Oncol. 2017 Dec; 116(7):831-840. PMID 28743160.
172. Silva JP, Berger NG, Tsai S, Christians KK, Clarke CN, Mogal H, White S, Rilling W, Gamblin TC. Transarterial Chemoembolization in Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis: A Systematic Review and Meta-analysis. HPB(Oxford). 2017 Aug; 19(8): 659-666.
173. Silva J, Hammad AY, Berger N, Rajeev R, Christians K, Tsai S, Miura J, Gamblin TC. Partial Hepatectomy Outcomes at Teaching and Non-teaching hospitals in the Modern Era: Analysis of the University Health System Consortium Database, J Hep & Gastr. 2017 Apr 14 [Epub ahead of print]
174. Barnes, CA, Krepline AN, Clarke CN, Christians KK, Aldakkak M, Khan AH, Hunt BC, Ritch PS, George B, Hall WA, Erickson BA, Evans DB, Tsai S. Is Adjuvant Therapy Necessary for Patients with Localized Pancreatic Cancer Who Have Received Neoadjuvant Therapy. Oral presentation 58th Annual SSAT meeting Chicago, IL 2017; J of Gastrointest Surg 2017 Nov; 21(11):1793-1803. PMID: 28849366.
175. Blitzer GC, Hall WA, Tsai S, Aldakkak M, Hellman RS, Evans DB, Christians KK, George B, Ritch PS, Erickson BA. Should functional renal scans be obtained prior to upper abdominal IMRT for pancreatic cancer? Pract Radiat Oncol. 2017 Nov-Dec; 7(6): e449-e455. PMID: 28886941.
176. Berger NG, Silva JP, Mogal H, Clarke CC, Bedi M, Charlson JA, Christians KK, Tsai S, Gamblin TC. Overall Survival after Resection for Retroperitoneal Sarcoma at Academic Cancer Centers vs Community Cancer Centers: An Analysis of the National Cancer Data Base. Surgery 2018 Feb; 163(2):318-323. PMID: 28943041.
177. Barnes CA, Krzywda E, Lahiff S, McDowell D, Christians KK, Knechtges P, Tolat P, Hohenwalter M, Dua K, Khan AH, Evans DB, Geurts J, Tsai S. Development of a high risk pancreatic screening clinic using 3.0T MRI. Presented at AHPBA, Miami, FL 3/2015. Fam Cancer. 2018 Jan; 17(1):101-111. PMID 29101607.
178. Silva JP, Berger NG, Yin Z, Liu Y, Tsai S, Christians KK, Clarke CN, Mogal H, Clark Gamblin T. Minimally Invasive Hepatectomy Conversions: an analysis of risk factors and outcomes. HPB(Oxford). 2018 Feb; 20(2): 132-139. PMID 29183702.
179. Bhalla M, Aldakkak M, Kulkarni NM, O'Connor SD, Griffin MO Jr, Christians KK, Evans DB, Tsai S, Tolat PP. Characterizing indeterminate liver lesions in patients with localized pancreatic cancer at the time of diagnosis. Abdom Radiol (NY). 2018; 43(2):351-363. PMID: 29185014.
180. Chatzizacharias N, Tsai S, Griffin M, Tolat P, Ritch PS, George B, Barnes C, Aldakkak M, Khan AH, Hall W, Erickson BA, Evans DB, Christians KK. Locally Advanced Pancreas Cancer - Staging and Goals of Therapy. Surgery. 2018 May;163(5):1053-1062.
181. Silva JP, Berger NG, Yin Z, Liu Y, Tsai S, Christians K, Clarke CN, Mogal H, Gamblin TC. The Effect of Prior Upper Abdominal Surgery on Outcomes Following Liver Transplantation for Hepatocellular Carcinoma: An Analysis of the Organ Procurement Transplant Network Database. Presented at 12th Annual Academic Surgical Congress, Las Vegas, 2/2017; Surgery. 2018; 163(5): 1028-1034. PMID 29398041.
182. Berger NG, Herren JL, Liu C, Burrow RH, Silva JP, Tsai S, Christians KK, Gamblin TC. Ablation approach for primary liver tumors: peri-operative outcomes. J Surg Oncol. 2018 Jun; 117(7): 1493-1499. PMID 29484654.
183. Liu C, Berger NG, Rein L, Tarima S, Clarke C, Mogal H, Christians KK, Tsai S, Gamblin TC. Gallbladder carcinoma: An analysis of the national cancer database to examine hispanic influence. J Surg Oncol. 2018; 117(8): 1664-1671. PMID 29714811.
184. Tsai S, Christians KK, George B, Ritch PS, Dua K, Khan A, Mackinnon AC, Tolat P, Ahmad SA, Hall WA, Erickson BA, Evans DB. A Phase II Clinical Trial of Molecular Profiled Neoadjuvant Therapy for Localized Pancreatic Ductal Adenocarcinoma. Presented at 138th Annual Meeting of the American Surgical Association Phoenix, AZ. Ann Surg. 2018; 268(4):610-619. PMID: 30080723.
185. Silva JP, Klooster B, Tsai S, Christians KK, Clarke CN, Mogal H, Gamblin TC. Elective Regional Therapy Treatment for Hepatic Adenoma. Ann Surg Oncol. 2019; 26(1):125-130. PMID 30353390.
186. Chavez MI, Tsai S, Clarke CN, Aldakkak M, Griffin MO, Khan AH, Ritch PS, Erickson BA, Evans DB, Christians KK. Distal splenorenal and mesocaval shunting at the time of pancreatectomy. Presented at AHPBA Miami, FL 3/9/18. Surgery 2019; 165(2): 298-306. PMID: 30471779.
187. Wilkinson KH, Ethun CG, Hembrook M, Bedi M, Charlson J; Mogal H, Tsai S, Christians K, Tran TB, Poultsides G, Grignol V, Howard JH, Tseng J, Roggin KK, Chouliaras K, Votanopoulos K, Cullinan D, Fields RC. Weber S, Gamblin TC, Cardona K, Clarke CN. Outcomes of Elderly Patients Undergoing Curative Resection for Retroperitoneal Sarcomas: Analysis from the US Sarcoma Collaborative. J Surg Res 2019; 233: 154-162. PMID: 30502242.
188. Silva JP, Maurina MN, Tsai S, Christians KK, Clarke CN, Mogal H, Saeian K, Gamblin TC. Effect of Donor Race-Matching on Overall Survival for African American Patients Undergoing Liver Transplantation for Hepatocellular Carcinoma. J Am Coll Surg. 2019; 228(3):245-254. PMID 30639515.
189. Morgan Z, Chow BE, Strong EA, Tsai S, Christians K, Mogal H, Gamblin TC, Clarke CN. RAS Mutation Status Confers Prognostic Relevance in Patients Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Colorectal Cancer. J Surg Res 2019; 240:130-135. PMID 30928770 Scopus ID 2-s2.0-85063410472.
190. Barnes CA, Chavez MI, Tsai S, Aldakkak M, George B, Ritch PS, Dua K, Clarke CN, Tolat P, Hagen C, Hall WH, Erickson BA, Evans DB and Christians KK. Survival of patients with borderline resectable pancreatic cancer who received neoadjuvant therapy and surgery. Presented at AHPBA, Miami, FL, 4/1/17. Surgery 2019; 166(3):277-285. PMID 31272811 Scopus ID 2-s2.0-85068174272
191. Jariwalla NR, Khan AH, Dua K, Christians KK, Clarke CN, Aldakkak M, George B, Tutton S, Rilling W, Erickson B, Evans DB and Tsai S. Management of Acute Cholecystitis During Neoadjuvant Therapy in Patients with Pancreatic Adenocarcinoma. Ann Surg Oncol. 2019 Dec; 26(13):4515-4521. PMID 31641946 Scopus ID: 2-s2.0-85074492297
192. Krepline AN, Bliss L, Geurts J, Akinola I, Christians KK, George B, Ritch PS, Hall WA, Erickson BA, Evans DB, Tsai S. Role of Molecular Profiling of Pancreatic Cancer After Neoadjuvant Therapy: Does It Change Practice? Presented at Plenary Session of SSAT 5/19/19; J Gastrointest Surg 2020; 24(2):235-242 PMID 31745905 Scopus ID 2-s2.0-85076028351.
193. Coon C, Berger N, Eastwood D, Tsai S, Christians K, Mogal H, Clarke C, Gamblin TC. Primary Liver Cancer: An NCDB Analysis of Overall Survival and Margins After Hepatectomy. Ann Surg Oncol 2020; 27(4): 1156-1163. PMID: 31677109 Scopus ID: 2-s2.0-85074715626.
194. Tsai S, George B, Wittmann D, Ritch PS, Krepline AN, Aldakkak M, Barnes CA, Christians KK, Dua K, Griffin M, Hagen C, Hall WA, Erickson BA, Evans DB. Importance of Normalization of Ca19-9 Levels Following Neoadjuvant Therapy in Patients with Localized Pancreatic Cancer. Ann Surg. 2020 271(4):740-747 PMID: 30312198.
195. Strong EA, Park SH, Ethun CG, Chow B, King D, Bedi M, Charlson J, Mogal H, Tsai S, Christians K, Tran TB, Poultsides G, Grignol V, Howard JH, Tseng J, Roggin KK, Chouliaras K, Votanopoulos K, Cullinan D, Fields RC, Gamblin TC, Cardona K, Clarke CN. High neutrophil-lymphocyte ratio is not independently associated with worse survival or recurrence in patients with extremity soft tissue sarcoma. Surgery 2020 Oct;168(4):760-767. PMID 32736869.
196. Barnes CA, Aldakkak M, Christians KK, Clarke CN, Dua K, George B, Ritch PS, Kamgar M, Hall WA, Kulkarni N, Erickson BA, Evans DB, Tsai S. Radiographic patterns of first disease recurrence after neoadjuvant therapy and surgery for patients with resectable and borderline resectable pancreas cancer. Surgery 2020 Sep;168(3):440-447. PMID: 32641278
197. Rowan DJ, Hartley CP, Aldakkak M, Christians KK, Evans DB, Tsai S, Hagen CE. Gross tumor size using the AJCC 8th ed. T staging criteria does not provide prognostic stratification for neoadjuvant treated pancreatic ductal adenocarcinoma. Ann Diagn Pathol 2020; Jun;46:151485 PMID 32172219.
198. Liu C, Rein L, Clarke C, Mogal H, Tsai S, Christians KK, Gamblin TC. Comparison of overall survival in gallbladder carcinoma at academic versus community cancer centers: An analysis of the National Cancer Data Base. J Surg Oncol 2020; 122(2): 176-182. PMID 32383268.
199. Barnes CA, Aldakkak M, Clarke CN, Christians KK, Bucklan D, Holt M, Tolat P, Ritch PS, George B, Hall WA, Erickson BA, Evans DB, Tsai S. Value of Pretreatment 18F-fluorodeoxyglucose Positron Emission Tomography in Patients with Localized Pancreatic Cancer Treated with Neoadjuvant Therapy. Front Oncol 2020; 10:500. PMID 32363161.
200. Krepline AN, Geurts JL, Akinola I, Christians KK, Clarke CN, George B, Ritch PS, Khan AH, Hall WA, Erickson BA, Griffin MO, Hagen C, Evans DB and Tsai S. Detection of Germline Variants Using Expanded Multigene Panels in Patients with Localized Pancreatic Cancer. Presented at Association of VA Surgeons Annual Meeting 4/27/19 Seattle, WA. HPB (Oxford) 2020; Apr 27 PMID: 32354656 Scopus ID: 2-s2.0-85083782398.
201. Wittmann D, Hall WA, Christians KK, Barnes CA, Jariwalla NR, Aldakkak M, Clarke CN, George B, Ritch PS, Riese M, Khan AH, Kulkarni N, Evans J, Erickson BA, Evans DB, Tsai S. Impact of Neoadjuvant Chemoradiation on Pathologic Response in Patients with Localized Pancreatic Cancer. Front Oncol 2020; 10: 460 PMID: 32351886 PMCID: PMC7175033 Scopus ID: 2-s2.0-85084010622 5/1/2020.
202. Muraki T, Reid MD, Pehlivanoglu B, Gonzales RS, Sekhar A, Memis B, Xue Y, Cheng J, Jang KT, Mittal P, Cardona K, Kooby DA, Maithel S, Sarmiento JM, El-Rayes B, Lomberk G, Urrutia RA, Christians K, Tsai S, Evans DB, Adsay V. Variant Anatomy of the Biliary System as a Cause of Pancreatic and Peri-ampullary Cancers. HPB (Oxford) 2020; 22(12);1675-1685.
203. Thalji SZ, Tsai S, Gamblin TC, Clarke C, Christians K, Charlson J, Ethun CG, Poultsides G, Grignol VP, Roggin KK, Votanopoulos K, Fields RC, Abbott DE, Cardona K, Mogal H US Sarcoma Collaborative. Outcomes of palliative-intent surgery in retroperitoneal sarcoma-results from the US Sarcoma Collaborative. J Surg Oncol 2020 121(7): 1140-1157 PMID 32167587 Scopus ID: 2-s2.0-85081732672 3/14/2020.
204. Hagen CE, Christians K, Hopp A, Giorgadze T, Hartley CP, Hunt B, Basturk O, Klimstra D. Intraductal papillary squamous neoplasm of the pancreas: Cysto-histologic correlation of a novel entity. Ann Diagn Path 2020; 48: 151583. PMID 32847795.
205. Kim RY, Evans DB, Christians KK. Locally advanced pancreatic cancer: staging, operability, and the importance of multimodality therapy. Hepatobiliary Surg Nutr 2020. 9(4):497-500. PMID 32832502.
206. Christians KK. Commentary: Venous resection and reconstruction at the time of pancreatectomy for cancer. Surgery 2020; Dec;168(6):1058-1059. PMID: 32977974.
207. Mora J, Krepline AN, Aldakkak M, Christians KK, George B, Hall WA, Erickson BA, Kulkarni N, Evans DB, Tsai S. Adjuvant Therapy Rates and Overall Survival in Patients with Localized Pancreatic Cancer from High Area Deprivation Index Neighborhoods. Am J Surg 2021; Jul; 222(1):10-17. PMID 33308823.
208. Kim RY, Christians KK, Aldakkak M, Clarke CN, George B, Kamgar K, Khan AH, Kulkarni N, Hall WA, Erickson BA, Evans DB, Tsai S. Total Neoadjuvant Therapy for Operable Pancreatic Cancer. Presented at AHPBA, Miami, FL 2020. Ann Surg Oncol 2021; 28(4):2246-2256. PMID 33000372.
209. Chavez MI, Gholami S, Kim BJ, Margonis GA, Ethun CG, Tsai S, Christians KK, Clarke C, Mogal H, Maithel SK, Pawlik TM, D'Angelica MI, Aloia TA, Eastwood D, Gamblin TC. Two-Stage Hepatectomy for Bilateral Colorectal Liver Metastases: A Multi-Institutional Analysis. Ann Surg Oncol 2021 Mar;28(3):1457-1465 PMID: 33393036.
210. Muraki T, Jang KT, Reid M, Pehlivanoglu B, Memis B, Basturk O, mittal P, Kooby D, Maithel S, Sarmiento J, Christians K, Tsai S, Evans DB, Adsay V. Pancreatic Ductal Adenocarcinomas associated with Intraductal Papillary Mucinous Neoplasms(IPMNs) versus pseudo-IPMNs: relative frequency, clinicopathologic characteristics and differential diagnosis. Modern Pathology; https://doi.org/10.1038/s41379-021-00902-x ; published online 13 September 2021. PMID: 34518632.
211. Christians KK and Evans DB. Pancreaticoduodenectomy and Vascular Reconstruction-Indications and Techniques. Surg Oncol Clin N Am 2021; 30: 731-746. PMID: 34511193.
212. Hall WA, Kamgar M, Erickson BA, Ponce SB, Tsai S, Nevalainen MT, Christians KK, George B, Dua KS, Khan AH, Evans DB and Asmi AS. Updates and New Directions in the Use of Radiation Therapy for the Treatment of Pancreatic Adenocarcinoma: Dose, Sensitization, and Novel Technology. Cancer and Metastasis Rev. 2021 Sep;40(3):879-889. PMID: 34611794
213. Yoshino O, Aldakkak M, Seadler B, Tsai S, Kim RY, Kamgar M, Hall WA, Clarke CN, George B, Erickson B, Khan AH, Evans DB and Christians KK. Arterial Divestment and Selective Arterial Resection and Reconstruction for Locally Advanced Pancreatic Cancer. Presented at AHPBA 8/3/21. In resubmission.
214. Ortiz de Choudens S, Visotcky A, Banerjee A, Aldakkak M, Tsai S, Evans DB, Christians KK, Clarke CN, George B, Shreenivas A, Kamgar M, Chakrabarti S, Dua KS, Khan AH, Madhavan S, Erickson BA, Hall WA. Characterization of an Oligometastatic State in Patients with Metastatic Pancreatic Adenocarcinoma Undergoing Systemic Chemotherapy. In Submission.
 
Books, Chapters, and Reviews
1. Christians KK, Evans DB, Pedrazzoli S, Pasquali C, Sperti C, Nakakura E, Duncan M, Eckhauser. Resection for Neoplasms of the Pancreas. Atlas of Upper GI and HPB Surgery 2nd edition. In press.
2. Pilgrim C, Evans DB and Christian KK. Technical Aspects of Pancreatic Surgery. Handbook of Pancreas and Hepatobiliary Surgery 1st edition. Submission 10/2012.
3. Christians, K., Quebbeman, E.: Colorectal Cancer Metastatic to the Liver: Non Resective Destructive Techniques. In Cameron JL, editor: Current Surgical Therapy 7th Edition, St. Louis, 2001, Mosby pp: 380-385.
4. Christians, K., Weigelt, J.A.: Ultrasound Use in the ICU. Operative Techniques in General Surgery Intensive Care Unit Procedures. WB Saunders, 2003, 5(3): 158-165.
5. Otterson, MF, Christians, K.: Radiation and Surgery. General Surgery: Principals and International Practice. Bland KI, Buchler MW, Csendes A, Garden OJ, Sarr MG and Wong J, Eds, Springer, 2009, pp 631-638.
6. Christians, K., Pitt, H.: Hepatic Abscess & Cystic Disease of the Liver. Maingot's Abdominal Operations (11th Edition). New York, 2007, McGraw Hill, Chapter 7, pp: 757-783.
7. Christians, K., Pitt, H.: Hepatic Abscess & Cystic Disease of the Liver. Maingot's Abdominal Operations (12th Edition). New York, 2013, McGraw Hill Medical, Chapter 42, pp: 901-925.
8. Lal, A, Christians, K., Evans, D. Vascular Reconstruction During the Whipple Operation. Current Surgical Therapy 10th edition. Cameron JL & Cameron AM, Eds. Elsevier Saunders, Philadelphia, 2011, 429-434.
9. Evans DB, Christians K, Foley, D. Pancreatectomy (Whipple Operation) and Total Pancreatectomy for Cancer. Mastery of Surgery 6th edition. Fischer JL Ed. Wolters Kluwer/Lippincot Williams & Wilkins, Philadelphia, 2012, 1445-1466.
10. Christians KK, Evans DB, Pedrazzoli S, Pasquali C, Sperti C, Nakakura E, Duncan M, Eckhauser F. Resection for Neoplasms of the Pancreas. Atlas of Upper GI and HPB Surgery 2nd edition. Clavien PA, Sarr MG. Springer-Verlag. Berlin Heidelberg 2016 Chapter 90. pp 831-871.
11. Pilgrim C, Evans DB and Christian KK. Technical Aspects of Pancreatic Surgery. Handbook of Hepato-Pancreato-Biliary Surgery. 1st edition. Zyromski NJ Ed. Wolters Kluwer, Philadelphia, 2015, 76-88.
12. Christians KK, Khan Abdul, Rilling William, Evans DB. Localization of Endocrine Pancreatic Tumors. Textbook of Endocrine Surgery 3rd edition. Rusko J and Clark, Eds. 2016, 1201-1208.
13. Christians KK, Thomas JP, Zechlinski J and Evans DB. PNET - Treatment Sequencing to include Principles of Surgery. Textbook of Complex General Surgical Oncology 1st edition. Morita SY, Balch CM, Klimberg VS, Pawlik TM, Posner MC, Tanabe KK eds. McGraw-Hill Companies Inc., China 2018, Chapter 146 pp1601-1607.
14. Amini A, Christians KK, Evans DB. Postpancreatectomy Hemorrhage: Early and Late. Gastrointestinal Surgery: Management of Complex Perioperative Complications. Pawlik TM, Maithel SK & Merchant NB Eds. Springer, New York, 2015, 271-280.
15. Tsai S, George B, Christians KK and Evans DB. Neoadjuvant chemotherapy and radiochemotherapy: is there a survival advantage for pancreatic cancer patients? Pancreatic Cancer, Cystic Neoplasms, and Endocrine Tumors: Diagnosis and Management. 1st Edition. Beger HG, Nakao A, Neoptolemos JP, Peng SY & Sarr MG Eds. Wiley Blackwell, West Sussex, UK, 2015, 103-119.
16. Fathi A, Tsai S, Lee JE, Evans DB, and Christians KK. Venous Shunting Procedures for Borderline and Locally Advanced Pancreatic Cancer. Multimodality Management of Borderline Resectable and Locally Advanced Pancreatic Cancer, 1st Edition. Katz M and Ahmad A. Eds. Switzerland: Springer Int Pub, 2016: 237-245.
17. Younan G, Tsai S, Evans DB and Christians KK. Neuroendocrine Tumors of the Pancreas. In Pancreas and Biliary Disorders: A Point-of-Care Clinical Guide. Dua KS and Shaker R Eds. Springer, Switzerland 2016, 131-151.
18. Barnes C, Christians KK, Evans DB and Tsai S. Pancreas Adenocarcinoma and Ampullary Cancer. In Pancreas and Biliary Disorders: A Point-of-Care Clinical Guide. Dua KS and Shaker R Eds. Springer, Switzerland 2016, 105-128.
19. Younan G, Evans DB, and Christians KK. Cavernous Transformation of the Portal Vein requiring Temporary Mesocaval Shunt and Internal Jugular Vein Interposition Graft. In Case-Based Lessons in the Management of Complex Hepato-Pancreato-Biliary Surgery. Pawlik T, Weber S, Gamblin TC Eds. Springer, Switzerland 2017, 375-383.
20. Evans DB, Tolat P, and Christians KK. Pancreatectomy (Whipple Operation) and Total Pancreatectomy for Cancer. Mastery of Surgery 7th edition. Fischer JL Ed. Wolters Kluwer/Lippincot Williams & Wilkins, Philadelphia. 2018: 127: 1552-1573.
21. Amini A, Evans DB, and Christians KK. Pancreaticoduodenectomy for Neuroendocrine Tumors. Atlas of Endocrine Surgery. Howe J., Lumley JSP Eds. Springer, Germany. 2017, 225-244.
22. Christians K, Younan G, George B, Tsai S and Evans DB. Resection versus chemotherapy for metastatic neuroendocrine tumors of the pancreas. Difficult Decisions in Endocrine Surgery: An Evidence-Based Approach. Angelos P and Grogan R Eds. Springer 2018, pp 441-457.
23. Chatzizacharias, N, Christians, KK., Pitt, H.: Hepatic Abscess & Cystic Disease of the Liver. Maingot's Abdominal Operations (13th Edition). Zinner MJ, Ashley SW, Hines OJ Eds. McGraw-Hill New York. 2019, Chapter 56 p1033-
24. Christians, K. New Classification of Locally Advanced Pancreatic Cancer. Tsai S, Ritch P, Erickson B and Evans DB Eds. Management of Localized Pancreatic Cancer. Switzerland: Springer Nature 2019. Chapter 9, 97-103.
25. Christians, K and Erickson B. Treatment Sequencing for Locally Advanced Pancreatic Cancer. Tsai S, Ritch P, Erickson B and Evans DB Eds. Management of Localized Pancreatic Cancer. Switzerland: Springer Nature 2019. Chapter 10, 105-112.
26. Christians K and Evans DB. Pancreaticoduodenectomy and Vascular Reconstruction: Indications and Techniques. Pawlik TM, Evans DB and Tsai S eds. Surg Oncol Clinics of North America Pennsylvania: Elsevier 2021. 30(4):731-736.
 
Editorials, Letters to Editor, Other
1. Christians, K., Quebbeman, E., Weigelt, J., and Gennarelli, T.: Innovations in Trauma Care.
2. Grand Rounds at Froedtert Hospital 6(4): 1-5, 1999.
3. Christians, K.: New Approaches to Liver Metastases. Grand Rounds at Froedtert Hospital 8(5): 5, 2001.
4. Christians, K., Quebbeman, J.: Hepatocellular Carcinoma - Multimodality Management. Froedtert &The Medical College Cancer Center Annual Report, pp: 10-13, 2001.
5. Christians, K.: Interest in Liver Disease Leads Surgeon to Hong Kong. Froedtert Today, v 9.3, pp: 12, December 2003.
6. Christians, K.: Tackling the Toughest of Cancers. Froedtert Today, v11.3, pp: 6-7, September 2006.
7. Christians, K., Quebbeman E.: Liver/Pancreas/Bile Duct Web Channel. Froedtert Hospital Website, Summer 2006 - Present.
8. Christians, K.: Hepato-Pancreatico-Biliary Surgery Program Brochure. Froedtert Hospital, Summer 2008.
9. Tcherniantchouk O, Ley E et al, Over Diagnosis of Heparin Induced Thrombocytopenia (HIT) in surgical ICU patients, reviewed for Western Surgical, 2010, November.
10. Christians K., Keim R and Evans DB. Borderline Resectable Pancreatic Cancer: Brief Report and Comment. Surgery Update, 2011: 3(1):2-3.
11. Evans DB., Tsai S, Ritch P and Christians K. Personalized Medicine for Pancreatic Cancer-Rationale and New Clinical Trial Available at the Medical College of Wisconsin. Surgery Update, 2011, 3(3):6-7.
12. Evans DB, Lahiff S, Krzywda B, Christians KK. Multidisciplinary Care and the Emergence of Multidisciplinary Conferences. Surgery Update. 2013; 5(3): 8-9.
13. Zechlinski J, Rilling W, Christians KK. Beyond Surgical Resection - Understanding Neuroendocrine Tumors. Surgery Update. 2015; 7(2): 10-11.
14. Christians KK. Venous Resection and Reconstruction at the time of Pancreatectomy for Cancer. Invited editorial. Surgery. 2020; 168(6):1058-1059. PMID: 32977974.
 
Abstracts
1. Pilgrim CHC, Mahmoud AF, Christians KK, Pappas SG, Turaga K, Quebbeman E, Gamblin TC, George B, Erickson BA, Kelly T, Ritch P, Evans DB and Tsai S. Minimal differences in biomarker profiling of resected pancreatic adenocarcinoma between patients receiving neoadjuvant therapy and those treated with surgery first. Submitted to SSO 9/22/12.
2. George B, Ritch P, Thomas JP, Wiebe LA, Mahmoud AF, Christians KK, Pappas SG, Turaga K, Quebbeman E, Gamblin TC, Erickson BA, Kelly T, Evans DB and Tsai S. Utility of pretreatment serum carcinoembryonic antigen (CEA) level in patients with Localized Pancreatic Cancer (LPCa). Submitted to GI ASCO 9/25/12.
3. Kharofa J, Kelly TR, George B, Ritch PS, Tsai S, Christians KK, Evans DB, Erickson B. Local control of resectable and borderline resectable pancreatic cancer (PCa) treated with preoperative chemoradiation using IMRT or chemotherapy alone. Submitted to 2013 Gastrointestinal Cancers Symposium, January 24-26,2013. Abstract # 105846.
4. Christians, K., and Quebbeman, E.: Progress in Liver Tumor Surgery. Wisconsin Surgical Society; Milwaukee, WI: August 26, 2000.
5. Dincer, A.P., Abu-Hajir, M., Christians, K., Gotschall, J.L., et al.: Human Recombinant Activated Factor Seven, NovoSeven (rVIIa), in the Management of Massive Bleeding Despite Adequate Resuscitation in Major Trauma. Abstract #3918, 44th Annual Meeting of the American Society of Hematology; Philadelphia, PA: December 6-10, 2002.
6. Christians, K., Brasel, K.B., Leipert, A., Weigelt, J.: Traumatic Extrahepatic Biliary Tract Injuries - What Should the Algorithm Be? Wisconsin Surgical Society; Kohler, Wisconsin: October 20, 2007.
7. Christians, K., Parisi, N., Wilson, S., Pappas, S., Krzywda, E., Graber, L., and Quebbeman, E.: Excessive and Unnecessary Testing Leads to Delay in Surgical Therapy for Operable Pancreatic Cancer. Wisconsin Surgical Society; Kohler, Wisconsin: November 8, 2008.
8. Rietema, E., Pappas, S., Christians, K., Quiroz, F., Quebbeman, E.: Microwave Ablation of Liver Tumors: An Initial Experience. Wisconsin Surgical Society, Milwaukee, WI: November 6, 2009.
9. Pappas S, Christians K., Quebbeman E, Evans D. Early Experience with The Frey Procedure in the Management of Chronic Pancreatitis in Southeastern Wisconsin. Wisconsin Surgical Society, Milwaukee, WI: November 7, 2009.
10. Pappas S, Christians K., Quebbeman E, Wilson S, Lahiff S, Cayo A. The Role of Cytoreductive Surgery for Goblet Cell Carcinomatosis. 5th Annual UPMC Perfusion Conference; February 5, 2010.
11. Christians K., Keim R, Ecker A, Wilson S, Gamblin TC, Evans DB, Quebbeman E, Pappas S. Local resection of Ampullary Tumors: A Management Approach. Wisconsin Surgical Society, Kohler, WI; November 6, 2010.
12. Riggle K, Keim R, Pappas S, Evans DB, and Christians K. Distal Splenorenal and Mesocaval Shunting at the Time of Pancreatectomy for Cancer. Wisconsin Surgical Society, Kohler, WI, November 4, 2011.
13. Groeschl RT, Christians KK, Pappas SG, Turaga KK, Tsai S, Quebbeman EJ, Gamblin TC. Hepatectomy for Metastatic Sarcoma to the Liver: A Multi-Institutional Analysis. Wisconsin Surgical Society (Kohler, WI): Nov 4-5, 2011.
14. Asare E, Green D, Ziang Q, Gamblin TC, Turaga K, Pappas SG, Christians K, Quebbeman E, Evans DB, Knechtges P and Tsai S. Low Baseline Lean Body Mass Predicts Completion of Neoadjuvant Therapy Among Patients with Resectable and Borderline Resectable Pancreatic Cancer. Presented - AHPBA, Miami, FLA, March 11, 2012.
15. Groeschl RT, Pappas SG, Christians KK, Tsai S, Quebbeman EJ, Gamblin TC, Turaga KK. Surgical Resection in Hepatocellular Carcinoma Patients with Minimal Background Fibrosis; A Strategy in the Era of Organ Shortage. 12th Annual Congress - AHPBA (Miami, FL): March 7-11, 2012 and 10th World Congress - IHPBA (Paris, France): July 1-5, 2012.
16. Kharofa J, Kelly TR, Ritch PS, George B, Wiebe LA, Thomas JP, Christians KK, Evans DB, Erickson E. 5-FU/Leucovorin, irinotecan, oxaliplatin (FOLFIRINOX) induction followed by chemoXRT in borderline resectable pancreatic cancer. ASCO. Abstract # 93798. 2012.
17. Groeschl RT, Wong RK, Rilling WS, Hieb RA, Christians KK, Tsai S, Quebbeman EJ, Turaga KK, Gamblin TC, Pappas SG. Glass Microsphere (Yttrium-90) Radioembolization for Hepatic Neuroendocrine Metastases. 10th World Congress - IHPBA (Paris, France): July 1-5, 2012.
18. Groeschl RT, Christians KK, Turaga KT and Gamblin TC. Management of Primary Hepatopancreaticobiliary Small Cell Carcinoma. Accepted for Quick Shot Presentation at 8th Annual Academic Surgical Congress, February 5-7, 2013, New Orleans, LA.
19. George B, Ritch P, Thomas JP, Wiebe LA, Mahmoud AF, Christians KK, Pappas SG, Turaga K, Quebbeman E, Gamblin TC, Erickson BA, Kelly T, Evans DB, and Tsai S. Utility of pretreatment serum carcinoembryonic antigen (CEA) level in patients with Localized Pancreatic Cancer (LPCa). ASCO 2013.
20. Kharofa J, Kelly TR, George B, Ritch PS, Tsai S, Christians KK, Evans DB, Erickson B. Local control of resectable and borderline resectable pancreatic cancer (PCa) treated with preoperative chemoradiation using IMRT or chemotherapy alone. Submitted to 2013 Gastrointestinal Cancers Symposium, January 24-26,2013. Abstract # 105846.
21. Tsai S, Gamblin TC, Turaga K, Pappas SG, Christians KK, Quebbeman EJ and Evans DB. Establishing an Integrated Biospecimen Bank and Multidisciplinary Database for Pancreatic Cancer. Association of VA Surgeons Milwaukee, WI, April 21-24, 2013.
22. Mahmoud A, Vikas H, Gamblin TC, Turaga K, Pappas SG, Christians KK, Quebbeman EJ, Evans DB and Tsai S. Elevated Neutrophil to Lymphocyte Ratio (NLR) is Associated with Reduced Disease-Free Survival in Pancreatic Cancer. Association of VA Surgeons Milwaukee, WI, April 21-24, 2013.
23. Pappas SG, Doffek KM, Christians KK, Quebbeman EJ, Evans DB and Wilson SW. The Gastrinoma Triangle Revisited: Duodenal Wall Gastrinoma and Pancreatic Gastrinoma Locations Predict Biological Behavior and Longevity. Accepted for presentation the International Association of Endocrine Surgeons meeting Helsinki, Finland, August 25th, 2013.
24. Mahmoud A, George B, Kelly T, Ritch P, Erickson BA, Evans DB, Christians KK, Tsai, S. Decline in serum Ca19-9 after neoadjuvant therapy is assocated with improved survival among borderline resectable pancreatic cancer patients. 2013 ASCO abstracts
25. Miura JT, Amini A, Jayakrishnan TT, Johnston FM, Tsai S, Christians KK, Gamblin TC, Turaga KK. Is Local Resection Adequate for T1 Stage Ampullary Cancer? AHPBA Annual Meeting (Miami, Florida): February 19-23, 2014 and 11th World Congress - IHPBA (Seoul, Korea): March 22-27, 2014.
26. Miura JT, Amini A, Jayakrishnan TJ, Tsai S, Christians KK, Johnston FM, Evans DB, Gamblin TC, Turaga KK. Defining the role of adjuvant external beam radiotherapy on resected adenocarcinoma of the ampulla of Vater. 67th Annual Cancer Symposium - Society of Surgical Oncology (Phoenix, AZ): March 12-15, 2014.
27. Miura JT, Jayakrishnan T, Eastwood D, Johnston FM, Tsai S, Christians KK, Turaga KK, Gamblin TC. Molecular Profiling in Gastric Cancer: Examining Potential Targets for Chemotherapy. 67th Annual Cancer Symposium - Society of Surgical Oncology (Phoenix, AZ): March 12-15, 2014.
28. Miura JT, Krepline, AN, Deluge, J, George, B, Ritch, PS, Erickson, BA, Thomas, JP, Mahmoud, A, Quebbeman, EJ, Turaga, KK, Johnston, F, Christians, KK, Gamblin, TC, Evans, DB, Tsai, S. Neoadjuvant Therapy for Pancreatic Cancer in Patients > age 75. 67th Annual Cancer Symposium - Society of Surgical Oncology (Phoenix, AZ): March 12-15, 2014 and 48th Annual Pancreas Club Meeting (Chicago, IL): May 2-4, 2014.
29. Heimler JW, Krepline AN, George B, Ritch PS, Erickson BA, Johnston FM, Christians KK, Evans DB and Tsai S. Survival Outcomes of Patients with Resectable Pancreatic Cancer Receiving Neoadjuvant Therapy. Central Surgical Assoc. Chicago, IL 2015.
30. Krepline AN, Aldakkak M, George B, Ritch PS, Erickson BA, Johnston F, Christians KK, Evans DB, Tsai S. Importance of Preoperative Ca 19-9 Levels in Patients with Localized Pancreatic Cancer Treated with Neoadjuvant Therapy. Oral presentation SSO Houston, TX, 2015.
31. Krzywda E, Lahiff S, McDowell D, George B, Ritch PS, Erickson BA, Johnston F, Christians KK, Evans DB, Tsai S, Geurts J. Utility of Establishing a Pancreas Cancer Screening Program within a High Volume Pancreatic Cancer Program. Accepted for long oral presentation AHPBA 3/13/15.
32. Miura JT, Johnston FM, Tsai S, George B, Thomas JP, Christians KK, Turaga KK, Pawlik TM, Gamblin TC. Chemotherapy for Surgically Resected Intrahepatic Cholangiocarcinoma: Lymph Node Status Influences Treatment Efficacy. 68th Annual Cancer Symposium - Society of Surgical Oncology (Houston, TX): March 25-28 2015.
33. Divakaran K, Shu X, Dittmar RL, Grewal J, Christians KK, Johnston FM, Evans DB, Huang CC, Wang L and Tsai S. Copy Number Variation in Cell Free DNA in Pancreatic Cancer Patients Undergoing Neoadjuvant Therapy. Pancreas Club, Washington DC, May 2015.
34. Aldakkak M, Tolat P, Johnston F, Christians KK, Evans DB, and Tsai S. Impact of Radiographic Tumor-Vein Contact on Survival in Patients with Resectable Pancreatic Cancer Treated with Neoadjuvant Therapy. Oral presentation Assoc VA Surgeons, Miami FL, 2015.
35. Miura J, Aldakkak MA, Krepline AN, George B, Ritch PS, Erickson BA, Johnston FM, Christians KK, Evans DB, Tsai S. Gender-based Differences in Survival Among Patients with Localized Pancreatic Cancer. Soc Black Acad Surg, Chapel Hill, NC, 2015.
36. Tsai S, Christians KK, Dua K, Khan AH, George B, Ritch PS, Hunt B, Rao A, Mackinnon AC, Evans DB. Rapid immunohistochemical analysis of pancreatic cancer cytology from endoscopic guided fine needle aspirates: A prospective clinical trial. Jan 2016. GI ASCO, San Francisco, CA.
37. Berger N, Hammad A, Johnston F, Christians K, Tsai S, Turaga KK and Gamblin TC. Improved Survival after Hepatectomy for Intrahepatic Cholangiocarcinoma at Academic Cancer Centers. Oral presentation Society of Surgical Oncology, Boston, MA, 3/3/16.
38. Berger NG, Rajeev R, Tsai S, Christians KK, Johnston FM, Gamblin TC, Turaga KK. Technique of ablation of primary liver tumors influences peri-operative outcomes. Quick Shot Presentation, Academic Surgical Congress, Jacksonville, FL, 2/2/16.
39. Berger N, Hammad AY, Tanious M, Younan G, Miura J, Turaga KK, Christians KK, Johnston F, Tsai S, Gamblin TC. External Radiation or Ablation for Solitary Hepatocellular Carcinoma: A Survival Analysis of the SEER Database. Oral presentation, IHPBA, Sao Paulo, Brazil, 4/21/16.
40. Berger N, Hammad A, Miura J, Johnston F, Christians K, Tsai S, Turaga KK, Gamblin TC.
41. Ablation for Small HCC Lesions: Is Chemotherapy Necessary? Oral Presentation, International Symposium on Regional Cancer Therapies, Chandler, AZ, 2/13/2016.
42. Berger N, Hammad A, Miura J, Johnston F, Christians K, S Tsai, KK Turaga, TC Gamblin. Overall Survival after Ablation for Small Size Hepatocellular Carcinoma at Academic Cancer Centers vs. Community Cancer Centers. Oral Presentation, International Symposium on Regional Cancer Therapies, Chandler, AZ. 2/13/2016.
43. Barnes CA, Aldakkak M, Christians KK, Ritch PS, George B, Johnston FM, Erickson BA, Tolat P, Foley WD, Evans DB and Tsai S. Impact of Treatment Sequencing on Sites of First Recurrence in Patients with Localized Pancreatic Cancer. SSAT, San Diego, CA, 5/21/2016 and Pancreas Club, San Diego, CA 5/2016.
44. Barnes CA, Aldakkak M, Christians KK, Ritch PS, George B, Johnston FM, Erickson BA, Hagen K, Oshima K, Evans DB and Tsai S. Impact of Number of Regional Lymph Node Metastasis in Patients with Localized Pancreatic Cancer Following Neoadjuvant Therapy. SSAT, San Diego, CA, 5/21/2016 and Pancreas Club, Chicago IL 2017.
45. Jeong S, Aldakkak M, Ahn KW, Huang CC, Christians KK, Erickson BA, Ritch PS, George B, Evans DB, Tsai S. Prognostic Nomogram for Patients with Operable Pancreatic Cancer Treated with Neoadjuvant Therapy. 12th Annual Academic Surgical Congress, Las Vegas, NV, 2/7/2017.
46. Jeong S, Aldakkak M, Ahn KW, Huang CC, Christians KK, Erickson BA, Ritch PS, George B, Evans DB, Tsai. Prognostic Nomogram for Operable Pancreatic Cancer (PC)Treated with Neoadjuvant Therapy. 2/2017 12th Annual Academic Surgical Congress. Las Vegas, NV.
47. Jeong S, Aldakkak M, Ahn KW, Huang CC, Christians KK, Erickson BA, Ritch PS, George B, Evans DB, Tsai. Preoperative Nomogram for Patients with Operable Pancreatic Cancer Treated with Neoadjuvant therapy. Mini Oral AHPBA 4/1/17 & poster presentation Pancreas Club 5/6/17.
48. Wittmann D, Aldakkak M, Rajamanickam EP, Christians KK, Abu Rajab M, George B, Ritch PS, Hall WA, Erickson BA, Evans DB, Tsai S. Impact of Perioperative Changes in Ca19-9 levels in Patients with Resectable and Borderline Resectable Pancreatic Cancer. Mini oral AHPBA 4/1/17 and Poster of Distinction Pancreas Club 5/6/17.
49. Barnes CA, Aldakkak M, Christians KK, Tolat P, Ritch PS, George B, Hall WA, Erickson BA, Evans DB, Tsai S. Prognostic Value of Positron Emission Tomography and Preoperative Ca 19-9 in Patients Treated on a Prospective Phase II Trial of Neoadjuvant Therapy and Surgery. Long oral presentation. 51st Annual Pancreas Club 5/6/17.
50. Barnes CA, Aldakkak M, Clarke C, Christians KK, George B, Ritch PS, Hall W, Erickson B, Evans DB, Tsai S. Importance of Adjuvant Therapy after Neoadjuvant Therapy Among Patients with Stage I-II Pancreatic Cancer: A National Cancer Database Analysis. Oral presentation. SBAS 5/6/17.
51. Krepline AN, Barnes CA, Aldakkak M, Akinola, I, Christians KK, Clarke, CC, George B, Ritch PS, Hall W, Erickson BA, Evans DB, Tsai S. Role of Neoadjuvant Radiation in Downstaging Patients with Localized Pancreatic Cancer - Analysis of the NCDB Database. Accepted for Mini Oral Presentation on 3/23/18.
52. Krepline AN, Aldakkak M, Christians KK, George B, Ritch PS, Hall WA, Erickson BA, Evans DB, Tsai S. Next Generation Sequencing of Pancreatic Cancer Tumor Specimens: Is More Testing Better? Presented at SSAT Plenary Session HPB 1, 5/19/19.
53. Livingston AJ, Strong E, Christians KK, Tsai S, Khan AH, Dua KS, Hunt B, Hagan C, Evans DB, Clarke CN. Accuracy of Ki-67 Index Obtained from FNA Specimens in the Diagnosis and Grading of Pancreatic Neuroendocrine Tumors. Accepted for Podium Presentation, American College of Surgeons 10/29/19.
54. Strong EA, Maciej G, Livingston A, Tsai S, Christians K, George B, Ritch P, Evans DB, Wong YL, Thomas JP, Clarke CN. Safety and Efficacy of Peptide Receptor Radionuceotide Therapy (PRRT) in Metastatic Neuroendocrine Tumors: A Single-Institution Experience Post FDA Approval. Accepted for Oral presentation SSO 2020.
55. Strong EA, Livingston A, Gracz M, Aldakkak M, Christians K, George B, Thomas J, Hall W, Erickson BA, Evans DB, Tsai S, Clarke CN. Somatic Mutation Testing in Sporadic Pancreatic Neuroendocrine Tumors: Is there a role? Submitted to SBAS, Milwaukee WI, 2020.
56. Kim RY, Tsai S, Aldakkak M, George B, Kamgar M, Kulkarni N, Erickson BA, Evans DB, Christians KK. Factors associated with overall survival in pancreatic cancer treated with neoadjuvant therapy and surgery. Presented at IHPBA 14th World Congress, Melbourne, Australia Feb 2-5, 2020 (virtual event due to COVID).
57. Kim RY, Tsai S, Budith R, Evans DB, Christians KK. Mesocaval Shunting to Decompress Cavernous Transformation in Pancreas Surgery. Presented at IHPBA 14th World Congress, Melbourne, Australia Feb 2-5, 2020 (virtual event due to COVID).
58. Livingston AJ, Strong E, Christians KK, Tsai S, Khan A, Dua K, Hunt B, Hagan C, Evans DB Clarke CN. Accuracy of Ki-67 Index Obtained From FNA Specimens in the Diagnosis and Grading of Pancreatic Neuroendocrine Tumors" Accepted for Podium Presentation at the American College of Surgeons 2019 Clinical Congress, San Francisco, CA.
59. Hall WA, Tsai S, Banerjee A, George B, Ritch PS, Thomas JP, Paulson E, Christians KK, Clarke CN, Dua KS, Khan A, Knechtges PM, Hagen CE, Evans DB and Erickson B. A Randomized, Phase II Clinical Trial of Preoperative Stereotactic Body Radiation Therapy vs Conventionally Fractionated Chemoradiation for Resectable, Borderline Resectable or Locally Advanced Type A Pancreatic Cancer. Presented at ASCO Trials In Progress 2019.
60. Yoshino O, Aldakkak M, Seadler B, Tsai S, Kim RY, Kamgar M, Hall WA, Clarke CN, George B, Erickson B, Khan AH, Evans DB, Christians KK. Arterial Divestment versus Arterial Resection/Reconstruction at the Time of Pancreatectomy for Locally Advanced Pancreas Cancer. Accepted for Oral presentation, AHPBA 8/3/2021 Annual Meeting, Miami, FL.
61. Thalji SZ, Aldakkak M, Christians KK, Clarke CN, George B, Kamgar M, Erickson BA, Hall WA, Khan AH, Tolat P, Giorgadze T, Evans DB and Tsai S. Goal-Directed Neoadjuvant Treatment of Operable Pancreatic Cancer: Achieving Ca19-9 Response to Chemotherapy Prior to Surgery. Accepted for Oral Presentation AHPBA 8/4/2021 Annual Meeting, Miami, FL.
62. Thalji SZ, Hall WA, Aldakkak M, Christians KK, CN Clarke, George B, Kamgar M, Hunt B, Madhavan S, Kulkarni N, Erickson BA, Evans DB, Tsai S. Patterns of Ca19-9 Response to Neoadjuvant Chemoradiation for Pancreatic Cancer Predict Differences in Survival. Accepted for presentation SSAT 5/23/21.
63. Yoshino, O, Aldakkak M, Josephson M, Christians KK, Tsai S, George B, Wong YL, Thomas J, Erickson BA, Hall WA, Khan AH, Kulkarni N, Evans J, Evans DB, Clarke CN. Oncologic Outcomes After Neoadjuvant Systemic Therapies in Pancreatic Neuroendocrine Tumors. Accepted for mini oral on demand presentation. AHPBA 8/2021 Annual Meeting, Miami, FL.
64. Ward E, Krepline AN, Christians KK, Clarke CN, George B, Ritch PS, Kamgar M, Chisholm P, Doucette S, Oconnor SD, Hall WA, Erickson BA, Evans DB and Tsai S. Prognostic Value of Carcinoembryonic Antigen(CEA) for Patients with Localized Pancreatic Cancer. Submitted to IHPBA 9/1/21.
65. Ward EP, Aldakkak M, Kersting K, Keiser L, Eastwood D, Christians KK, Clarke CN, Evans DB, Tsai S. Impact of Neoadjuvant Treatment on Psychosocial Wellbeing in Patients with Pancreatic Cancer. Accepted for Oral Presentation, SSO 2022.
66. Mehdi M, Annunzio K, Taylor B, Szabo A, Schreeniva A, Chakrabarti S, Thomas J, Tsai S, Christians K, Evans D, Clarke C, Hall W, Erickson B, Ahmed G, Thapa B, George B, Kamgar M. Impact of KRAS alterations in Pancreatic Ductal Adenocarcinoma (PDAC). Submitted to ASCO 2021.
67. Barnes CA, Ward E, Merrill J, Verhagen NB, Loy V, Clarke CN, Christians KK, Maduekwe UN, Gamblin TC, Kothari AN. Characteristics of High Performing Facilities Treating Patients with Colorectal Liver Metastases: An Analysis of the National Cancer Database.
68. Submitted to SSAT 12/2/21.
69. SenthilKumar G, Koerber N, Merrill J, Clarke CN, Maduekwe UN, Tsai S, Christians KK, Gamblin TC and Kothari AN. Feasibility of Automatic Machine Learning (AutoML) to Predict 90-Day Mortality after Gastrectomy for Cancer. Submitted to SSAT 12/2/21.
70. Posters:
71. Neisen, M.J., Rilling, W.S., Hieb, R.A., Hohenwalter, E.J., Tutton, S.M., Christians, K.K., Quebbeman, E.J., Franco, J., Saeian, K.: Results of Chemoembolization for Unresectable Hepatocellular Carcinoma in Patients with and Without Chronic Liver Disease. World Conference on Interventional Oncology Meeting, Washington DC, May 14-17, 2007.
72. Christians KK, Pappas SG, Quebbeman EJ, Graber L, Krzywda EA, Wilson SD, Evans DB. Duplicate Pancreas Meets Gastric Duplication Cyst: A Tale of Two Anomalies. 44th Annual Pancreas Club Meeting, May 2, 2010.
73. Keim R, Rao A, Vonhoff DD, Evans DB, and Christians K.K. Molecular Profiling of Endoscopic Ultrasound (EUS)-Guided Fine Needle Aspiration (FNA) Specimens in Pancreas Cancer: A Feasibility Study. Pancreas Club, Chicago, Illinois; May 6-7, 2011.
74. Keim RL, Christians KK, Harris RC, Wilson S, Gamblin TC, Pappas S. The Frey Procedure for Chronic Pancreatitis: A Single-Institution Experience. Pancreas Club, Chicago, Illinois; May 6-7, 2011.
75. Groeschl R, Pappas S, Christians K, Tsai S, Quebbeman E, Gamblin TC, and Turaga K. Hepatic Hemangioendothelioma: A Population-Based Analysis of a Rare Vascular Tumor. Wisconsin Surgical Society, Kohler, WI, November 4, 2011.
76. Groeschl RT, Pappas SG, Christians KK, Tsai S, Quebbeman EJ, Gamblin TC, Turaga KT. Does a Common Vascular Origin Confer Similar Prognosis to Malignant Tumors of the Liver? Gastrointestinal Cancers Symposium - ASCO (San Francisco, CA): Jan 19-21, 2012 and 65th Annual Cancer Symposium - Society of Surgical Oncology (Orlando, FL): March 21-24, 2012.
77. Groeschl RT, Pappas SG, Christians KK, Tsai S, Quebbeman EJ, Gamblin TC, Turaga KT. Are We Justified in Excluding Patients with Combined Hepatocellular-Cholangiocarcinoma from Transplantation? ASCO (San Francisco, CA): Jan 19-21, 2012 and 65th Annual Cancer Symposium - Society of Surgical Oncology (Orlando, FL): March 21-24, 2012.
78. Pilgrim CHC, Mahmoud AF, Christians KK, Pappas SG, Turaga K, Quebbeman E, Gamblin TC, George B, Erickson BA, Kelly T, Ritch P, Evans DB, and Tsai S. Minimal differences in biomarker profiling of resected pancreatic adenocarcinoma between patients receiving neoadjuvant therapy and those treated with surgery first. Accepted for poster presentation 66th Annual Cancer Symposium - Society of Surgical Oncology (Washington DC): March 6-9, 2013.
79. Tsai S, Ritch P, Kelly T, Quebbeman EJ, Evans DB, Mackinnon AC, Christians KK. Phase II clinical trial of biomarker-directed therapy for localized pancreatic cancer. ASCO. Chicago, IL. 2013.
80. Baruah D, Tolat P, Sullivan J, Christians K, Laguna M. Pancreaticoportal fistula -- A rare complication of pancreatitis. Accepted for poster presentation European Congress of Radiology (Vienna, Austria): March 7-11, 2013.
81. Pilgrim C, Mahmoud A, Chen X, Gonzalez L, West A, Gamblin TC, Turaga K, Christians KK, Quebbeman EJ, Evans DB, Mackinnon AC, and Tsai S. Neoadjuvant Therapy Increases Secreted Protein Acidic and Rich in Cysteine (SPARC) Expression in Resected Pancreatic Adenocarcinoma: Prognostic Implications. Accepted for Pancreas Club Meeting Poster of Distinction session, May 18-19, 2013, Orlando, FL.
82. Green DE, Pilgrim CHC, Christians KK, Zhao S, Szabo A, Turaga KK, Tsai S, Wiebe LA, Evans DB, Pappas SG. QOL in Patients with Pancreatic Adenocarcinoma Undergoing Neoadjuvant Therapy. Accepted for poster presentation Pancreas Club Meeting May 18-19, 2013, Orlando, FL.
83. Groeschl RT, Pilgrim CHC, Hanna EM, Simo KA, Swan RZ, Sindram D, Martinie JM, Iannitti DA, Bloomston M, Schmidt C, Khabiri H, Shirley LA, Martin RC, Christians KK, Rilling WS, Gamblin TC. Microwave Ablation for Hepatic Malignancies: A Multi-Institutional Analysis. Gastrointestinal Cancers Symposium - ASCO (San Francisco, CA): Jan 24-26, 2013.
84. Duelge, KJ, Krepline, AN, Mahmoud, A, George, B, Ritch, PS, Erickson, BA, Quebbeman, EJ, Turaga, KK, Johnston, F, Gamblin, TC, Christians, KK, Evans, DB, Tsai, S. Survival Benefit of Adjuvant Therapy for Borderline Resectable (BLR) Pancreatic Cancer (PC) Patients Treated with Neoadjuvant Therapy. Poster presentation AHPBA 2/22/12.
85. Krepline AN, Duelge K, George B, Ritch PS, Erickson BA, Thomas JP, Mahmoud A, Quebbeman EJ, Turaga KK, Johnston FM, Gamblin TC, Christians KK, Evans DB, Tsai S. Prophylactic anticoagulation for superior mesenteric vein (SMV) or portal vein (PV) narrowing/occlusion in borderline resectable (BLR) pancreatic adenocarcinoma (PC) patients. Poster presentation AHPBA. Miami, FL. 2/21/14.
86. Amini, A, Krepline, AN, Mahmoud, A, George, B, Ritch, PS, Erickson, BA, Thomas, JP, Quebbeman, EJ, Turaga, KK, Johnston, F, Gamblin, TC, Christians, KK, Evans, DB, Tsai, S. Feasibility of Resection after Induction Therapy for Locally Advanced Pancreatic Cancer. Poster Presentation SSO Meeting, Phoenix, AZ. 2014.
87. Tsai S, Christians KK, Dua K, Khan A, Oh Y, George B, Ritch P, Erickson BA, Hunt B, Rao A, Mackinnon AC, Evans DE. Rapid immunohistochemical analysis of pancreatic cancer cytology from endoscopic ultrasound guided fine needle aspirates. AACR, New Orleans, LA. 2014.
88. Miura J, Krepline AN, Deluge J, George B, Ritch PS, Erickson BA, Thomas JP, Mahmoud A, Quebbeman EJ, Turaga KK, Johnston F, Christians KK, Gamblin TC, Evans DB, Tsai S. Neoadjuvant Therapy for Pancreatic Cancer in Patients > age 75. SSO, Phoenix AZ, 2014.
89. Divakaran K, Palen K, Christians KK, Johnston F, Evans DB, Gershan J, Tsai S. Depletion of Contaminating Murine Stromal Cells Using Flow Cytometric Sorting of Human Pancreatic Cancer Xenografts. SSO. Houston, TX, 2015.
90. Divakaran K, Shu X, Dittmar RL, Grewal J, Christians KK, Johnston FM, Evans DB, Huang L, Tsai S. Copy Number Variation in Cell Free DNA in Pancreatic Cancer Patients Undergoing Neoadjuvant Therapy. AACR. Philadelphia, PA, 2015.
91. Misustin SM, Christians KK, Johnston FM, Krzywda EA, Lahiff SL, Tsai S, Evans DB. Readmission after Pancreatectomy for Cancer: a Data-Driven Approach to Quality Improvement. Accepted for poster presentation AHPBA 3/14/15.
92. Heimler JW, Krepline AN, George B, Ritch PS, Erickson BA, Johnston F, Christians KK, Evans DB, Tsai S. Survival Outcome of Patients with Resectable Pancreatic Cancer (PC) Receiving Neoadjuvant Therapy. Accepted for poster presentation Central Surgical Society 2015.
93. Krepline AN, Christians KK, George B, Ritch PS, Erickson BA, Oshima K, Tolat P, Evans DB and Tsai S. Does the MD Anderson (MDA) Criteria of Borderline Resectable (BLR) Pancreatic Cancer (PC) Impact Successful Completion of Neoadjuvant Therapy and Survival?
94. Accepted for poster presentation AHPBA 3/14/15.
95. MIURA JT, Groesch RT, Johnston FM, Tsai S, Christians KK, Turaga KK, Gamblin TC. Surgical Resection versus Ablation for Hepatocellular Carcinoma Less Than 3cm: A Population Based Analysis. A-PHPBA Annual Meeting (Singapore): March 18-21, 2015.
96. MIURA JT, Johnston FM, Tsai S, George B, Thomas J, Eastwood D, Banerjee A, Christians KK, Turaga KK, Pawlik TM, Gamblin TC. Chemotherapy for Surgically Resected Intrahepatic Cholangiocarcinoma: Lymph Node Status Influences Treatment Efficacy. Gastrointestinal Cancers Symposium - ASCO (San Francisco, CA): January 2015.
97. Tsai S, Christians KK, Dua K, Khan AH, George B, Ritch PS, Hunt B, Rao A, Mackinnon AC, Evans DB. Rapid immunohistochemical analysis of pancreatic cancer cytology from endoscopic guided fine needle aspirates: A prospective clinical trial. Jan 2016. GI ASCO, San Francisco, CA
98. Ritch P, Erickson B, George B, Christians K, Mackinnon A, Evans DB and Tsai S. Rapid Immunohistochemical Analysis of Pancreatic Cytology from Endoscopic Ultrasound-Guided Fine-Needle Aspirates: A Prospective Clinical Trial. Accepted for Poster presentation GI ASCO 2016.
99. Berger N, Hammad A, Miura J, Johnston F, Christians K, Tsai S, Turaga KK, Gamblin TC. Overall Survival after Ablation for Small Size Hepatocellular Carcinoma at Academic Cancer Centers vs Community Cancer Centers. Accepted for poster presentation ASCO-GI, San Francisco, CA 1/22/2016.
100. Berger N, Hammad A, Miura J, Johnston F, Christians K, Tsai S, Turaga K, Gamblin T. Overall Survival and Resection Margin after Hepatectomy for Intrahepatic Cholangiocarcinoma at Academic Centers Vs. Community Care Center. Poster. GI Cancer Symposium. San Francisco, CA. January 2016.
101. Hammad A, Younan G, Rajeev R, Berger N, Turaga K, Johnston F, Christians K, Gamblin T. Is Radiotherapy Warranted Following Intrahepatic Cholangiocarcinoma Resection? The Impact of Surgical Margins and Lymph Node Status on Survival. Poster. GI Cancer Symposium. San Francisco, CA. January 2016.
102. Berger NG, Rajeev R, Tsai S, Christians KK, Johnston FM, Gamblin TC, Turaga KK. Technique of ablation of primary liver tumors influences peri-operative outcomes. Poster Presentation. NSQIP Annual Conference. San Diego, CA. July 2016.
103. Berger NG, Hammad AY, Miura JT, Eastwood D, Banerjee A, Christians KK, Tsai S, Gamblin TC. Improved Survival after Hepatectomy for Primary Liver Cancer at Academic Cancer Centers. MCW Fall Research Day. Milwaukee WI. July 2016.
104. Berger NG, Kim BJ, Gholami S, Margonis GA, Ethun CG, Silva JP, Tsai S, Christians KK, Mogal H, Clarke C, Maithel SK, Pawlik TM, D'Angelica MI, Aloia TA, Gamblin TC. Two-stage hepatectomy for colorectal liver metastases: A multi-institutional retrospective review. GI Cancer Symposium. San Francisco, CA. January 2017.
105. Silva JP, Berger NG, Tsai S, Christians KK, Clarke CN, Mogal H, Gamblin TC. Does hepatectomy approach influence transfusion? An analysis of the National Surgical Quality Improvement Program database. GI Cancer Symposium. San Francisco, CA. January 2017.
106. Silva JP, Berger NG, Tsai, Christians KK, Clarke CN, Mogal H, Gamblin TC. Minimally invasive hepatectomy conversions: An analysis of outcomes. GI Cancer Symposium. San Francisco, CA. January 2017.
107. Blitzer GC, Tsai S, Aldakkak M, Hellman RS, Evans DB, Christians KK, George B, Ritch PS, Hall WA, Erickson BA. Should functional renal scans be obtained prior to upper abdominal radiation for pancreatic cancer? Poster Presentation, ASCO Gastrointestinal Cancers Symposium, San Francisco, CA. 1/19-21/2017.
108. George B, Bailey M, Schrock AB, Thorpe L, Gay LM, Ritch P, Thomas JP, Erickson B, Tsai S, Christians KK, Evans DB, Stephens PJ, Miller VA, Ross JS, Singhi AD, Ali SM
109. Impact of age on genomic alterations associated with pancreatic ductal adenocarcinoma. Poster Presentation, ASCO Gastrointestinal Cancers Symposium, San Francisco, CA. 1/19-21/2017.
110. Barnes CA, Aldakkak M, Christians KK, Ritch PS, George B, Johnston FM, Erickson BA, Tolat P, Foley WD, Evans DB, Tsai S. Impact of Treatment Sequencing on Sites of First Recurrence in Patients with Localized Pancreatic Cancer. Poster presentation. SSAT. San Diego, CA, 5/2016.
111. Barnes CA, Aldakkak M, Christians KK, Khan AH, Oshima K, Ritch PS, George B, Hall WA, Erickson BA, Evans DB and Tsai S. Impact of Nodal Status on Adjuvant Therapy for Patients with Localized Pancreatic Cancer Treated with Neoadjuvant Therapy. Poster presentation. Pancreas Club 5/6/17.
112. Barnes CA, Aldakkak M, Christians KK, Ritch PS, George B, Johnston FM, Erickson BA, Hagan C, Oshima K, Evans DB, Tsai S. Impact of Number of Regional Lymph Node Metastasis in Patient with Localized Pancreatic Cancer Following Neoadjvuant Therapy. 51st Annual Pancreas Club. 2017 Chicago, IL
113. Wittmann,D, Aldakkak M, Rajamanickam EP, Christians KK, Aburajab M, George B, Ritch PS, Hall WA, Erickson BA, Evans, DB, Tsai S. Impact of perioerative changes in CA19-9 levels in patients with resectable and borderline resectable pancreatic cancer. Poster of Distinction. 51st Annual Pancreas Club. 2017 Chicago, IL.
114. Jeong SY, Aldakkak M , Ahn K, Huang C, Christians KK, EricksonBA, Ritch PS, George B, Evans DB, Tsai S. Preoperative Nomogram to Predict Survival for Patients with Resectable and Borderline Resectable Pancreatic Cancer. 51st Annual Pancreas Club. 2017 Chicago, IL
115. Yoshino O, Aldakkak M, Seadler B, Tsai S, Kamgar M, Hall WA, George B, Clarke CN, Erickson B, Evans DB and Christians KK. Impact of portal vein resection on survival in pancreatic cancer. Accepted for e-Poster presentation, Scientific Forum at ACS Clinical Congress 2021.
116. Ward EP, Christian KK, Kamgar M, George B, Aldakkak M, O'Connor S, Miller J, Smith Z, Hall WA, Erickson B, Evans DB, Tsai S. PreTreatment Ca 19-9 Impacts Overall Survival Among Patients Who have a Normal Postoperative Ca19-9 following Neoadjuvant Therapy and Surgery - Implications for Adjuvant Therapy. Accepted for E-poster presentation at ACS Clinical Congress 2021.
117. De Choudens SO, Visotcky A, Banerjee, Aldakkak M, Tsai S, Evans DB, Christians KK, Clarke CN, George B, Shreenivas A, Kamgar M, Chakrabarti S, Dua KS, Khan AH, Erickson BA, Hall WA. Examination for the Presence of An Oligo-Metastatic State In Patients with Newly Diagnosed Metastatic Pancreatic Adenocarcinoma Undergoing Systemic Chemotherapy. Accepted for poster presentation at ASTRO 2021.
118. Mehdi MB, Annunzio K, Taylor B, Szabo A, Shreenivas A, Chakrabarti S, Thomas J, Tsai S, Christians K, Evans DB, Clarke CN, Hall WA, Erickson BA, Ahmed G, Thapa B, George B, Kamgar M. Impact of KRAS alterations in Pancreatic Ductal Adenocarcinoma (PDAC). Accepted for poster presentation ASCO 2021.
119. Hall WA, Khan HY, Kamgar M, Tsai S, Christians KK, Evans DB, Phillip PA, Clarke CN, George B, Erickson B, Azmi AS. Targeting cellular metabolism with CPI-613 sensitizes pancreatic cancer cells to radiotherapy. Submitted to AACR 9/21/21 for poster.
120. Ortiz de Choudens S, Visotcky A, Banerjee A, Aldakkak M, Tsai S, Evans DB, Christians KK, Clarke CN, George B, Shreenivas A, Kamgar M, Chakrabarti S, Dua KS, Khan AH, Erickson BA and Hall WA. Examination for the Presence of An Oligo-Metastatic State in Patients with Newly Diagnosed Metastatic Pancreatic Adenocarcinoma Undergoing Systemic Chemotherapy. Accepted for poster presentation at ASTRO. 2/24/21
121. Ahmed G, Annunzio K, Szabo A, Eastman D, Thapa B, Taylor B, Tsai S, Christians K, Clarke C, Evans D, Hall WA, Erickson B, Kamgar M, George B. Clinical outcomes in Pancreatic Ductal Adenocarcinoma (PDAC) patients with underlying Autoimmune disease. Submitted to ASCO 2021.
122. Mehdi MB, Annunzio K; Taylor B, Szabo, A Shreenivas A, Chakrabarti S, Thomas, J, Tsai S, Christians, K, Evans, D, Clarke C, Hall W; Wittmann, BE; Ahmed G, Thapa B; George B, Kamgar, M. Treatment of KRAS WT Pancreatic Ductal Adenocarcinoma (PDAC) with Targeted Therapy (TT) Elicits Durable Responses. Accepted for Poster Presentation ASCO GI 1/20-22, 2022.
123. Shreenivas A, George B, Chakrabarti S, Kamgar M, Thomas JP, Smolock A, Hall W, Awan M, Straza M, Christians KK, Gamblin TC, Tsai S, Puckett L, Hong JC, Loy V, Durazo F, Rilling W, Danziger N, Dougherty K, Ross J. Comparison of Comprehensive Genomic Profiling (CGP) of Fibrolamellar Oncocytic hepatoma (FLO) and Conventional Hepatocellular Carcinoma (HCC). Accepted for poster presentation ASCO GI 2022.